Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Stepping Up to STEM Act of 2013
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
S. 358 - STEM Master Teacher Corps Act of 2013 H.R. 1243 - Innovation Inspiration School Grant Program Act - to promote STEM education H.R. 1089 - Stepping up to STEM Act of 2013 - to promote STEM education
Innovation Inspiration School Grant Program Act
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
S. 358 - STEM Master Teacher Corps Act of 2013 H.R. 1243 - Innovation Inspiration School Grant Program Act - to promote STEM education H.R. 1089 - Stepping up to STEM Act of 2013 - to promote STEM education
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
BOSTON SCIENTIFIC CORPORATION via BOSTON SCIENTIFIC CORPORATION
2013 · first_quarter · Q1
H.R. 624 - CyberIntelligence Sharing & Protection Act (CISPA) of 2013 - A bill to promote Industry and Government sharing of cyber intelligence
S. 358 - STEM Master Teacher Corps Act of 2013 H.R. 1243 - Innovation Inspiration School Grant Program Act - to promote STEM education H.R. 1089 - Stepping up to STEM Act of 2013 - to promote STEM education
Source: Senate LDA
STEM Master Teacher Corps Act of 2013
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
S. 358 - STEM Master Teacher Corps Act of 2013 H.R. 1243 - Innovation Inspiration School Grant Program Act - to promote STEM education H.R. 1089 - Stepping up to STEM Act of 2013 - to promote STEM education
Novel Device Regulatory Relief Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the FDA medical device regulatory system particularly to promote greater efficiency, transparency, and predictability, particularly through the 510(k) system. The following bills accomplish those goals: H.R. 3209 - Premarket Predicability Act H.R. 3203 - Novel Device Regulatory Relief Act H.R. 3230 - Keeping America Competitive through Harmonization Act H.R. 3205 - FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 - Humanitarian Device Reform Act H.R. 3208 - Patients Come First Act H.R. 3206 - Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 - Food and Drug Administration Mission Reform Act H.R. 3207 - Modernizing Laboratory Test Standards for Patients Act H.R. 3204 - Guidance Accountability and Transparency Act H.R. 3847 - Safety of Untested and New Devices Act of 2012 H.R. 3975 - A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 H.R. 4056 - Science and Technology Regulatory Relief Act H.R. 5651 - Food and Drug Administration Reform Act 2012 S. 1700 - The Medical Device Regulatory Improvement Act S. 1865 - The Patient Access to Medical Innovation Act S. 1943 - Novel Device Regulatory Relief Act of 2011 S. 1972 - A bill to amend the Food and Drug Administration's mission S. 1995 - A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. S. 2067 - Safe, Transparent, and Efficient Medical Device Act S. 2113 - A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health S. 2193 - Ensuring Safe Medical Devices for Patients S. 3187 - A bill to amend the Federal Food, Drug, and Cosetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes
Novel Device Regulatory Relief Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the medical device regulatory system particularly for Class II devices through the 510(k) system including the following FDA related legislation: H.R. 3209 -Premarket Predictability Act H.R. 3203 -Novel Device Regulatory Relief Act H.R. 3230 -Keeping America Competitive through Harmonization Act H.R. 3205 -FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 -Humanitarian Device Reform Act H.R. 3208 -Patients Come First Act H.R. 3206 -Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 -Food and Drug Administration Mission Reform Act H.R. 3207 -Modernizing Laboratory Test Standards for Patients Act H.R. 3204 -Guidance Accountability and Transparency Act H.R. 3847- Safety of Untested and New Devices Act of 2012 H.R. 3975- A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 H.R. 4056- Science and Technology Regulatory Relief Act S. 1700 -The Medical Device Regulatory Improvement Act S. 1865 -The Patient Access to Medical Innovation Act S. 1943 -Novel Device Regulatory Relief Act of 2011 S. 1972 -A bill to amend the Food and Drug Administration's mission S. 1995 -A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. S. 2067- Safe, Transparent, and Efficient Medical Device Act S.2113- A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health S. 2193- Ensuring Safe Medical Devices for Patients Discussion drafts on user fee legislation from the Energy and Commerce Committee and the Health, Education, Labor and Pensions Committee
Novel Device Regulatory Relief Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the medical device regulatory system particularly for Class II devices through the 510(k) system including the following FDA related legislation: H.R. 3209 -Premarket Predictability Act H.R. 3203 -Novel Device Regulatory Relief Act H.R. 3230 -Keeping America Competitive through Harmonization Act H.R. 3205 -FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 -Humanitarian Device Reform Act H.R. 3208 -Patients Come First Act H.R. 3206 -Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 -Food and Drug Administration Mission Reform Act H.R. 3207 -Modernizing Laboratory Test Standards for Patients Act H.R. 3204 -Guidance Accountability and Transparency Act H.R. 3847- Safety of Untested and New Devices Act of 2012 H.R. 3975- A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 H.R. 4056- Science and Technology Regulatory Relief Act H.R. 5651- Food and Drug Administration Reform Act of 2012 S. 1700 -The Medical Device Regulatory Improvement Act S. 1865 -The Patient Access to Medical Innovation Act S. 1943 -Novel Device Regulatory Relief Act of 2011 S. 1972 -A bill to amend the Food and Drug Administration's mission S. 1995 -A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. S. 2067- Safe, Transparent, and Efficient Medical Device Act S.2113- A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health S. 2193- Ensuring Safe Medical Devices for Patients S.3187- A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes
Guidance Accountability and Transparency Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the FDA medical device regulatory system particularly to promote greater efficiency, transparency, and predictability, particularly through the 510(k) system. The following bills accomplish those goals: H.R. 3209 - Premarket Predicability Act H.R. 3203 - Novel Device Regulatory Relief Act H.R. 3230 - Keeping America Competitive through Harmonization Act H.R. 3205 - FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 - Humanitarian Device Reform Act H.R. 3208 - Patients Come First Act H.R. 3206 - Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 - Food and Drug Administration Mission Reform Act H.R. 3207 - Modernizing Laboratory Test Standards for Patients Act H.R. 3204 - Guidance Accountability and Transparency Act H.R. 3847 - Safety of Untested and New Devices Act of 2012 H.R. 3975 - A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 H.R. 4056 - Science and Technology Regulatory Relief Act H.R. 5651 - Food and Drug Administration Reform Act 2012 S. 1700 - The Medical Device Regulatory Improvement Act S. 1865 - The Patient Access to Medical Innovation Act S. 1943 - Novel Device Regulatory Relief Act of 2011 S. 1972 - A bill to amend the Food and Drug Administration's mission S. 1995 - A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. S. 2067 - Safe, Transparent, and Efficient Medical Device Act S. 2113 - A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health S. 2193 - Ensuring Safe Medical Devices for Patients S. 3187 - A bill to amend the Federal Food, Drug, and Cosetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes
Guidance Accountability and Transparency Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the medical device regulatory system particularly for Class II devices through the 510(k) system including the following FDA related legislation: H.R. 3209 -Premarket Predictability Act H.R. 3203 -Novel Device Regulatory Relief Act H.R. 3230 -Keeping America Competitive through Harmonization Act H.R. 3205 -FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 -Humanitarian Device Reform Act H.R. 3208 -Patients Come First Act H.R. 3206 -Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 -Food and Drug Administration Mission Reform Act H.R. 3207 -Modernizing Laboratory Test Standards for Patients Act H.R. 3204 -Guidance Accountability and Transparency Act H.R. 3847- Safety of Untested and New Devices Act of 2012 H.R. 3975- A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 H.R. 4056- Science and Technology Regulatory Relief Act S. 1700 -The Medical Device Regulatory Improvement Act S. 1865 -The Patient Access to Medical Innovation Act S. 1943 -Novel Device Regulatory Relief Act of 2011 S. 1972 -A bill to amend the Food and Drug Administration's mission S. 1995 -A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. S. 2067- Safe, Transparent, and Efficient Medical Device Act S.2113- A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health S. 2193- Ensuring Safe Medical Devices for Patients Discussion drafts on user fee legislation from the Energy and Commerce Committee and the Health, Education, Labor and Pensions Committee
Guidance Accountability and Transparency Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the medical device regulatory system particularly for Class II devices through the 510(k) system including the following FDA related legislation: H.R. 3209 -Premarket Predictability Act H.R. 3203 -Novel Device Regulatory Relief Act H.R. 3230 -Keeping America Competitive through Harmonization Act H.R. 3205 -FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 -Humanitarian Device Reform Act H.R. 3208 -Patients Come First Act H.R. 3206 -Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 -Food and Drug Administration Mission Reform Act H.R. 3207 -Modernizing Laboratory Test Standards for Patients Act H.R. 3204 -Guidance Accountability and Transparency Act H.R. 3847- Safety of Untested and New Devices Act of 2012 H.R. 3975- A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 H.R. 4056- Science and Technology Regulatory Relief Act H.R. 5651- Food and Drug Administration Reform Act of 2012 S. 1700 -The Medical Device Regulatory Improvement Act S. 1865 -The Patient Access to Medical Innovation Act S. 1943 -Novel Device Regulatory Relief Act of 2011 S. 1972 -A bill to amend the Food and Drug Administration's mission S. 1995 -A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. S. 2067- Safe, Transparent, and Efficient Medical Device Act S.2113- A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health S. 2193- Ensuring Safe Medical Devices for Patients S.3187- A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes
FDA Renewing Efficiency From Outside Reviewer Management Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the medical device regulatory system particularly for Class II devices through the 510(k) system including the following FDA related legislation: H.R. 3209 -Premarket Predictability Act H.R. 3203 -Novel Device Regulatory Relief Act H.R. 3230 -Keeping America Competitive through Harmonization Act H.R. 3205 -FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 -Humanitarian Device Reform Act H.R. 3208 -Patients Come First Act H.R. 3206 -Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 -Food and Drug Administration Mission Reform Act H.R. 3207 -Modernizing Laboratory Test Standards for Patients Act H.R. 3204 -Guidance Accountability and Transparency Act H.R. 3847- Safety of Untested and New Devices Act of 2012 H.R. 3975- A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 H.R. 4056- Science and Technology Regulatory Relief Act S. 1700 -The Medical Device Regulatory Improvement Act S. 1865 -The Patient Access to Medical Innovation Act S. 1943 -Novel Device Regulatory Relief Act of 2011 S. 1972 -A bill to amend the Food and Drug Administration's mission S. 1995 -A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. S. 2067- Safe, Transparent, and Efficient Medical Device Act S.2113- A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health S. 2193- Ensuring Safe Medical Devices for Patients Discussion drafts on user fee legislation from the Energy and Commerce Committee and the Health, Education, Labor and Pensions Committee
FDA Renewing Efficiency From Outside Reviewer Management Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the medical device regulatory system particularly for Class II devices through the 510(k) system including the following FDA related legislation: H.R. 3209 -Premarket Predictability Act H.R. 3203 -Novel Device Regulatory Relief Act H.R. 3230 -Keeping America Competitive through Harmonization Act H.R. 3205 -FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 -Humanitarian Device Reform Act H.R. 3208 -Patients Come First Act H.R. 3206 -Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 -Food and Drug Administration Mission Reform Act H.R. 3207 -Modernizing Laboratory Test Standards for Patients Act H.R. 3204 -Guidance Accountability and Transparency Act H.R. 3847- Safety of Untested and New Devices Act of 2012 H.R. 3975- A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 H.R. 4056- Science and Technology Regulatory Relief Act H.R. 5651- Food and Drug Administration Reform Act of 2012 S. 1700 -The Medical Device Regulatory Improvement Act S. 1865 -The Patient Access to Medical Innovation Act S. 1943 -Novel Device Regulatory Relief Act of 2011 S. 1972 -A bill to amend the Food and Drug Administration's mission S. 1995 -A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. S. 2067- Safe, Transparent, and Efficient Medical Device Act S.2113- A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health S. 2193- Ensuring Safe Medical Devices for Patients S.3187- A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes
FDA Renewing Efficiency From Outside Reviewer Management Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the FDA medical device regulatory system particularly to promote greater efficiency, transparency, and predictability, particularly through the 510(k) system. The following bills accomplish those goals: H.R. 3209 - Premarket Predicability Act H.R. 3203 - Novel Device Regulatory Relief Act H.R. 3230 - Keeping America Competitive through Harmonization Act H.R. 3205 - FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 - Humanitarian Device Reform Act H.R. 3208 - Patients Come First Act H.R. 3206 - Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 - Food and Drug Administration Mission Reform Act H.R. 3207 - Modernizing Laboratory Test Standards for Patients Act H.R. 3204 - Guidance Accountability and Transparency Act H.R. 3847 - Safety of Untested and New Devices Act of 2012 H.R. 3975 - A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 H.R. 4056 - Science and Technology Regulatory Relief Act H.R. 5651 - Food and Drug Administration Reform Act 2012 S. 1700 - The Medical Device Regulatory Improvement Act S. 1865 - The Patient Access to Medical Innovation Act S. 1943 - Novel Device Regulatory Relief Act of 2011 S. 1972 - A bill to amend the Food and Drug Administration's mission S. 1995 - A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. S. 2067 - Safe, Transparent, and Efficient Medical Device Act S. 2113 - A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health S. 2193 - Ensuring Safe Medical Devices for Patients S. 3187 - A bill to amend the Federal Food, Drug, and Cosetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes
Cultivating Scientific Expertise to Foster Innovation for Patients Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the medical device regulatory system particularly for Class II devices through the 510(k) system including the following FDA related legislation: H.R. 3209 -Premarket Predictability Act H.R. 3203 -Novel Device Regulatory Relief Act H.R. 3230 -Keeping America Competitive through Harmonization Act H.R. 3205 -FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 -Humanitarian Device Reform Act H.R. 3208 -Patients Come First Act H.R. 3206 -Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 -Food and Drug Administration Mission Reform Act H.R. 3207 -Modernizing Laboratory Test Standards for Patients Act H.R. 3204 -Guidance Accountability and Transparency Act H.R. 3847- Safety of Untested and New Devices Act of 2012 H.R. 3975- A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 H.R. 4056- Science and Technology Regulatory Relief Act H.R. 5651- Food and Drug Administration Reform Act of 2012 S. 1700 -The Medical Device Regulatory Improvement Act S. 1865 -The Patient Access to Medical Innovation Act S. 1943 -Novel Device Regulatory Relief Act of 2011 S. 1972 -A bill to amend the Food and Drug Administration's mission S. 1995 -A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. S. 2067- Safe, Transparent, and Efficient Medical Device Act S.2113- A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health S. 2193- Ensuring Safe Medical Devices for Patients S.3187- A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes
Cultivating Scientific Expertise to Foster Innovation for Patients Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the FDA medical device regulatory system particularly to promote greater efficiency, transparency, and predictability, particularly through the 510(k) system. The following bills accomplish those goals: H.R. 3209 - Premarket Predicability Act H.R. 3203 - Novel Device Regulatory Relief Act H.R. 3230 - Keeping America Competitive through Harmonization Act H.R. 3205 - FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 - Humanitarian Device Reform Act H.R. 3208 - Patients Come First Act H.R. 3206 - Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 - Food and Drug Administration Mission Reform Act H.R. 3207 - Modernizing Laboratory Test Standards for Patients Act H.R. 3204 - Guidance Accountability and Transparency Act H.R. 3847 - Safety of Untested and New Devices Act of 2012 H.R. 3975 - A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 H.R. 4056 - Science and Technology Regulatory Relief Act H.R. 5651 - Food and Drug Administration Reform Act 2012 S. 1700 - The Medical Device Regulatory Improvement Act S. 1865 - The Patient Access to Medical Innovation Act S. 1943 - Novel Device Regulatory Relief Act of 2011 S. 1972 - A bill to amend the Food and Drug Administration's mission S. 1995 - A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. S. 2067 - Safe, Transparent, and Efficient Medical Device Act S. 2113 - A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health S. 2193 - Ensuring Safe Medical Devices for Patients S. 3187 - A bill to amend the Federal Food, Drug, and Cosetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes
Cultivating Scientific Expertise to Foster Innovation for Patients Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the medical device regulatory system particularly for Class II devices through the 510(k) system including the following FDA related legislation: H.R. 3209 -Premarket Predictability Act H.R. 3203 -Novel Device Regulatory Relief Act H.R. 3230 -Keeping America Competitive through Harmonization Act H.R. 3205 -FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 -Humanitarian Device Reform Act H.R. 3208 -Patients Come First Act H.R. 3206 -Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 -Food and Drug Administration Mission Reform Act H.R. 3207 -Modernizing Laboratory Test Standards for Patients Act H.R. 3204 -Guidance Accountability and Transparency Act H.R. 3847- Safety of Untested and New Devices Act of 2012 H.R. 3975- A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 H.R. 4056- Science and Technology Regulatory Relief Act S. 1700 -The Medical Device Regulatory Improvement Act S. 1865 -The Patient Access to Medical Innovation Act S. 1943 -Novel Device Regulatory Relief Act of 2011 S. 1972 -A bill to amend the Food and Drug Administration's mission S. 1995 -A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. S. 2067- Safe, Transparent, and Efficient Medical Device Act S.2113- A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health S. 2193- Ensuring Safe Medical Devices for Patients Discussion drafts on user fee legislation from the Energy and Commerce Committee and the Health, Education, Labor and Pensions Committee
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the medical device regulatory system particularly for Class II devices through the 510(k) system including the following FDA related legislation: H.R. 3209 -Premarket Predictability Act H.R. 3203 -Novel Device Regulatory Relief Act H.R. 3230 -Keeping America Competitive through Harmonization Act H.R. 3205 -FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 -Humanitarian Device Reform Act H.R. 3208 -Patients Come First Act H.R. 3206 -Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 -Food and Drug Administration Mission Reform Act H.R. 3207 -Modernizing Laboratory Test Standards for Patients Act H.R. 3204 -Guidance Accountability and Transparency Act H.R. 3847- Safety of Untested and New Devices Act of 2012 H.R. 3975- A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 H.R. 4056- Science and Technology Regulatory Relief Act H.R. 5651- Food and Drug Administration Reform Act of 2012 S. 1700 -The Medical Device Regulatory Improvement Act S. 1865 -The Patient Access to Medical Innovation Act S. 1943 -Novel Device Regulatory Relief Act of 2011 S. 1972 -A bill to amend the Food and Drug Administration's mission S. 1995 -A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. S. 2067- Safe, Transparent, and Efficient Medical Device Act S.2113- A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health S. 2193- Ensuring Safe Medical Devices for Patients S.3187- A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the medical device regulatory system particularly for Class II devices through the 510(k) system including the following FDA related legislation: H.R. 3209 -Premarket Predictability Act H.R. 3203 -Novel Device Regulatory Relief Act H.R. 3230 -Keeping America Competitive through Harmonization Act H.R. 3205 -FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 -Humanitarian Device Reform Act H.R. 3208 -Patients Come First Act H.R. 3206 -Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 -Food and Drug Administration Mission Reform Act H.R. 3207 -Modernizing Laboratory Test Standards for Patients Act H.R. 3204 -Guidance Accountability and Transparency Act H.R. 3847- Safety of Untested and New Devices Act of 2012 H.R. 3975- A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 H.R. 4056- Science and Technology Regulatory Relief Act S. 1700 -The Medical Device Regulatory Improvement Act S. 1865 -The Patient Access to Medical Innovation Act S. 1943 -Novel Device Regulatory Relief Act of 2011 S. 1972 -A bill to amend the Food and Drug Administration's mission S. 1995 -A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. S. 2067- Safe, Transparent, and Efficient Medical Device Act S.2113- A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health S. 2193- Ensuring Safe Medical Devices for Patients Discussion drafts on user fee legislation from the Energy and Commerce Committee and the Health, Education, Labor and Pensions Committee
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the FDA medical device regulatory system particularly to promote greater efficiency, transparency, and predictability, particularly through the 510(k) system. The following bills accomplish those goals: H.R. 3209 - Premarket Predicability Act H.R. 3203 - Novel Device Regulatory Relief Act H.R. 3230 - Keeping America Competitive through Harmonization Act H.R. 3205 - FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 - Humanitarian Device Reform Act H.R. 3208 - Patients Come First Act H.R. 3206 - Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 - Food and Drug Administration Mission Reform Act H.R. 3207 - Modernizing Laboratory Test Standards for Patients Act H.R. 3204 - Guidance Accountability and Transparency Act H.R. 3847 - Safety of Untested and New Devices Act of 2012 H.R. 3975 - A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 H.R. 4056 - Science and Technology Regulatory Relief Act H.R. 5651 - Food and Drug Administration Reform Act 2012 S. 1700 - The Medical Device Regulatory Improvement Act S. 1865 - The Patient Access to Medical Innovation Act S. 1943 - Novel Device Regulatory Relief Act of 2011 S. 1972 - A bill to amend the Food and Drug Administration's mission S. 1995 - A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. S. 2067 - Safe, Transparent, and Efficient Medical Device Act S. 2113 - A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health S. 2193 - Ensuring Safe Medical Devices for Patients S. 3187 - A bill to amend the Federal Food, Drug, and Cosetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes
Patients Come First Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the medical device regulatory system particularly for Class II devices through the 510(k) system including the following FDA related legislation: H.R. 3209 -Premarket Predictability Act H.R. 3203 -Novel Device Regulatory Relief Act H.R. 3230 -Keeping America Competitive through Harmonization Act H.R. 3205 -FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 -Humanitarian Device Reform Act H.R. 3208 -Patients Come First Act H.R. 3206 -Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 -Food and Drug Administration Mission Reform Act H.R. 3207 -Modernizing Laboratory Test Standards for Patients Act H.R. 3204 -Guidance Accountability and Transparency Act H.R. 3847- Safety of Untested and New Devices Act of 2012 H.R. 3975- A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 H.R. 4056- Science and Technology Regulatory Relief Act H.R. 5651- Food and Drug Administration Reform Act of 2012 S. 1700 -The Medical Device Regulatory Improvement Act S. 1865 -The Patient Access to Medical Innovation Act S. 1943 -Novel Device Regulatory Relief Act of 2011 S. 1972 -A bill to amend the Food and Drug Administration's mission S. 1995 -A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. S. 2067- Safe, Transparent, and Efficient Medical Device Act S.2113- A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health S. 2193- Ensuring Safe Medical Devices for Patients S.3187- A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes
Patients Come First Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the FDA medical device regulatory system particularly to promote greater efficiency, transparency, and predictability, particularly through the 510(k) system. The following bills accomplish those goals: H.R. 3209 - Premarket Predicability Act H.R. 3203 - Novel Device Regulatory Relief Act H.R. 3230 - Keeping America Competitive through Harmonization Act H.R. 3205 - FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 - Humanitarian Device Reform Act H.R. 3208 - Patients Come First Act H.R. 3206 - Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 - Food and Drug Administration Mission Reform Act H.R. 3207 - Modernizing Laboratory Test Standards for Patients Act H.R. 3204 - Guidance Accountability and Transparency Act H.R. 3847 - Safety of Untested and New Devices Act of 2012 H.R. 3975 - A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 H.R. 4056 - Science and Technology Regulatory Relief Act H.R. 5651 - Food and Drug Administration Reform Act 2012 S. 1700 - The Medical Device Regulatory Improvement Act S. 1865 - The Patient Access to Medical Innovation Act S. 1943 - Novel Device Regulatory Relief Act of 2011 S. 1972 - A bill to amend the Food and Drug Administration's mission S. 1995 - A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. S. 2067 - Safe, Transparent, and Efficient Medical Device Act S. 2113 - A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health S. 2193 - Ensuring Safe Medical Devices for Patients S. 3187 - A bill to amend the Federal Food, Drug, and Cosetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes
Patients Come First Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the medical device regulatory system particularly for Class II devices through the 510(k) system including the following FDA related legislation: H.R. 3209 -Premarket Predictability Act H.R. 3203 -Novel Device Regulatory Relief Act H.R. 3230 -Keeping America Competitive through Harmonization Act H.R. 3205 -FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 -Humanitarian Device Reform Act H.R. 3208 -Patients Come First Act H.R. 3206 -Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 -Food and Drug Administration Mission Reform Act H.R. 3207 -Modernizing Laboratory Test Standards for Patients Act H.R. 3204 -Guidance Accountability and Transparency Act H.R. 3847- Safety of Untested and New Devices Act of 2012 H.R. 3975- A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 H.R. 4056- Science and Technology Regulatory Relief Act S. 1700 -The Medical Device Regulatory Improvement Act S. 1865 -The Patient Access to Medical Innovation Act S. 1943 -Novel Device Regulatory Relief Act of 2011 S. 1972 -A bill to amend the Food and Drug Administration's mission S. 1995 -A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. S. 2067- Safe, Transparent, and Efficient Medical Device Act S.2113- A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health S. 2193- Ensuring Safe Medical Devices for Patients Discussion drafts on user fee legislation from the Energy and Commerce Committee and the Health, Education, Labor and Pensions Committee
Premarket Predictability Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the FDA medical device regulatory system particularly to promote greater efficiency, transparency, and predictability, particularly through the 510(k) system. The following bills accomplish those goals: H.R. 3209 - Premarket Predicability Act H.R. 3203 - Novel Device Regulatory Relief Act H.R. 3230 - Keeping America Competitive through Harmonization Act H.R. 3205 - FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 - Humanitarian Device Reform Act H.R. 3208 - Patients Come First Act H.R. 3206 - Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 - Food and Drug Administration Mission Reform Act H.R. 3207 - Modernizing Laboratory Test Standards for Patients Act H.R. 3204 - Guidance Accountability and Transparency Act H.R. 3847 - Safety of Untested and New Devices Act of 2012 H.R. 3975 - A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 H.R. 4056 - Science and Technology Regulatory Relief Act H.R. 5651 - Food and Drug Administration Reform Act 2012 S. 1700 - The Medical Device Regulatory Improvement Act S. 1865 - The Patient Access to Medical Innovation Act S. 1943 - Novel Device Regulatory Relief Act of 2011 S. 1972 - A bill to amend the Food and Drug Administration's mission S. 1995 - A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. S. 2067 - Safe, Transparent, and Efficient Medical Device Act S. 2113 - A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health S. 2193 - Ensuring Safe Medical Devices for Patients S. 3187 - A bill to amend the Federal Food, Drug, and Cosetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes
Premarket Predictability Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the medical device regulatory system particularly for Class II devices through the 510(k) system including the following FDA related legislation: H.R. 3209 -Premarket Predictability Act H.R. 3203 -Novel Device Regulatory Relief Act H.R. 3230 -Keeping America Competitive through Harmonization Act H.R. 3205 -FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 -Humanitarian Device Reform Act H.R. 3208 -Patients Come First Act H.R. 3206 -Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 -Food and Drug Administration Mission Reform Act H.R. 3207 -Modernizing Laboratory Test Standards for Patients Act H.R. 3204 -Guidance Accountability and Transparency Act H.R. 3847- Safety of Untested and New Devices Act of 2012 H.R. 3975- A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 H.R. 4056- Science and Technology Regulatory Relief Act H.R. 5651- Food and Drug Administration Reform Act of 2012 S. 1700 -The Medical Device Regulatory Improvement Act S. 1865 -The Patient Access to Medical Innovation Act S. 1943 -Novel Device Regulatory Relief Act of 2011 S. 1972 -A bill to amend the Food and Drug Administration's mission S. 1995 -A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. S. 2067- Safe, Transparent, and Efficient Medical Device Act S.2113- A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health S. 2193- Ensuring Safe Medical Devices for Patients S.3187- A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes
Premarket Predictability Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the medical device regulatory system particularly for Class II devices through the 510(k) system including the following FDA related legislation: H.R. 3209 -Premarket Predictability Act H.R. 3203 -Novel Device Regulatory Relief Act H.R. 3230 -Keeping America Competitive through Harmonization Act H.R. 3205 -FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 -Humanitarian Device Reform Act H.R. 3208 -Patients Come First Act H.R. 3206 -Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 -Food and Drug Administration Mission Reform Act H.R. 3207 -Modernizing Laboratory Test Standards for Patients Act H.R. 3204 -Guidance Accountability and Transparency Act H.R. 3847- Safety of Untested and New Devices Act of 2012 H.R. 3975- A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 H.R. 4056- Science and Technology Regulatory Relief Act S. 1700 -The Medical Device Regulatory Improvement Act S. 1865 -The Patient Access to Medical Innovation Act S. 1943 -Novel Device Regulatory Relief Act of 2011 S. 1972 -A bill to amend the Food and Drug Administration's mission S. 1995 -A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. S. 2067- Safe, Transparent, and Efficient Medical Device Act S.2113- A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health S. 2193- Ensuring Safe Medical Devices for Patients Discussion drafts on user fee legislation from the Energy and Commerce Committee and the Health, Education, Labor and Pensions Committee
Humanitarian Device Reform Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the medical device regulatory system particularly for Class II devices through the 510(k) system including the following FDA related legislation: H.R. 3209 -Premarket Predictability Act H.R. 3203 -Novel Device Regulatory Relief Act H.R. 3230 -Keeping America Competitive through Harmonization Act H.R. 3205 -FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 -Humanitarian Device Reform Act H.R. 3208 -Patients Come First Act H.R. 3206 -Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 -Food and Drug Administration Mission Reform Act H.R. 3207 -Modernizing Laboratory Test Standards for Patients Act H.R. 3204 -Guidance Accountability and Transparency Act H.R. 3847- Safety of Untested and New Devices Act of 2012 H.R. 3975- A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 H.R. 4056- Science and Technology Regulatory Relief Act S. 1700 -The Medical Device Regulatory Improvement Act S. 1865 -The Patient Access to Medical Innovation Act S. 1943 -Novel Device Regulatory Relief Act of 2011 S. 1972 -A bill to amend the Food and Drug Administration's mission S. 1995 -A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. S. 2067- Safe, Transparent, and Efficient Medical Device Act S.2113- A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health S. 2193- Ensuring Safe Medical Devices for Patients Discussion drafts on user fee legislation from the Energy and Commerce Committee and the Health, Education, Labor and Pensions Committee
Humanitarian Device Reform Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the medical device regulatory system particularly for Class II devices through the 510(k) system including the following FDA related legislation: H.R. 3209 -Premarket Predictability Act H.R. 3203 -Novel Device Regulatory Relief Act H.R. 3230 -Keeping America Competitive through Harmonization Act H.R. 3205 -FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 -Humanitarian Device Reform Act H.R. 3208 -Patients Come First Act H.R. 3206 -Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 -Food and Drug Administration Mission Reform Act H.R. 3207 -Modernizing Laboratory Test Standards for Patients Act H.R. 3204 -Guidance Accountability and Transparency Act H.R. 3847- Safety of Untested and New Devices Act of 2012 H.R. 3975- A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 H.R. 4056- Science and Technology Regulatory Relief Act H.R. 5651- Food and Drug Administration Reform Act of 2012 S. 1700 -The Medical Device Regulatory Improvement Act S. 1865 -The Patient Access to Medical Innovation Act S. 1943 -Novel Device Regulatory Relief Act of 2011 S. 1972 -A bill to amend the Food and Drug Administration's mission S. 1995 -A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. S. 2067- Safe, Transparent, and Efficient Medical Device Act S.2113- A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health S. 2193- Ensuring Safe Medical Devices for Patients S.3187- A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes
Humanitarian Device Reform Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the FDA medical device regulatory system particularly to promote greater efficiency, transparency, and predictability, particularly through the 510(k) system. The following bills accomplish those goals: H.R. 3209 - Premarket Predicability Act H.R. 3203 - Novel Device Regulatory Relief Act H.R. 3230 - Keeping America Competitive through Harmonization Act H.R. 3205 - FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 - Humanitarian Device Reform Act H.R. 3208 - Patients Come First Act H.R. 3206 - Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 - Food and Drug Administration Mission Reform Act H.R. 3207 - Modernizing Laboratory Test Standards for Patients Act H.R. 3204 - Guidance Accountability and Transparency Act H.R. 3847 - Safety of Untested and New Devices Act of 2012 H.R. 3975 - A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 H.R. 4056 - Science and Technology Regulatory Relief Act H.R. 5651 - Food and Drug Administration Reform Act 2012 S. 1700 - The Medical Device Regulatory Improvement Act S. 1865 - The Patient Access to Medical Innovation Act S. 1943 - Novel Device Regulatory Relief Act of 2011 S. 1972 - A bill to amend the Food and Drug Administration's mission S. 1995 - A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. S. 2067 - Safe, Transparent, and Efficient Medical Device Act S. 2113 - A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health S. 2193 - Ensuring Safe Medical Devices for Patients S. 3187 - A bill to amend the Federal Food, Drug, and Cosetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes
Food and Drug Administration Mission Reform Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the medical device regulatory system particularly for Class II devices through the 510(k) system including the following FDA related legislation: H.R. 3209 -Premarket Predictability Act H.R. 3203 -Novel Device Regulatory Relief Act H.R. 3230 -Keeping America Competitive through Harmonization Act H.R. 3205 -FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 -Humanitarian Device Reform Act H.R. 3208 -Patients Come First Act H.R. 3206 -Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 -Food and Drug Administration Mission Reform Act H.R. 3207 -Modernizing Laboratory Test Standards for Patients Act H.R. 3204 -Guidance Accountability and Transparency Act H.R. 3847- Safety of Untested and New Devices Act of 2012 H.R. 3975- A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 H.R. 4056- Science and Technology Regulatory Relief Act S. 1700 -The Medical Device Regulatory Improvement Act S. 1865 -The Patient Access to Medical Innovation Act S. 1943 -Novel Device Regulatory Relief Act of 2011 S. 1972 -A bill to amend the Food and Drug Administration's mission S. 1995 -A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. S. 2067- Safe, Transparent, and Efficient Medical Device Act S.2113- A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health S. 2193- Ensuring Safe Medical Devices for Patients Discussion drafts on user fee legislation from the Energy and Commerce Committee and the Health, Education, Labor and Pensions Committee
Food and Drug Administration Mission Reform Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the medical device regulatory system particularly for Class II devices through the 510(k) system including the following FDA related legislation: H.R. 3209 -Premarket Predictability Act H.R. 3203 -Novel Device Regulatory Relief Act H.R. 3230 -Keeping America Competitive through Harmonization Act H.R. 3205 -FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 -Humanitarian Device Reform Act H.R. 3208 -Patients Come First Act H.R. 3206 -Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 -Food and Drug Administration Mission Reform Act H.R. 3207 -Modernizing Laboratory Test Standards for Patients Act H.R. 3204 -Guidance Accountability and Transparency Act H.R. 3847- Safety of Untested and New Devices Act of 2012 H.R. 3975- A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 H.R. 4056- Science and Technology Regulatory Relief Act H.R. 5651- Food and Drug Administration Reform Act of 2012 S. 1700 -The Medical Device Regulatory Improvement Act S. 1865 -The Patient Access to Medical Innovation Act S. 1943 -Novel Device Regulatory Relief Act of 2011 S. 1972 -A bill to amend the Food and Drug Administration's mission S. 1995 -A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. S. 2067- Safe, Transparent, and Efficient Medical Device Act S.2113- A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health S. 2193- Ensuring Safe Medical Devices for Patients S.3187- A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes
Food and Drug Administration Mission Reform Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the FDA medical device regulatory system particularly to promote greater efficiency, transparency, and predictability, particularly through the 510(k) system. The following bills accomplish those goals: H.R. 3209 - Premarket Predicability Act H.R. 3203 - Novel Device Regulatory Relief Act H.R. 3230 - Keeping America Competitive through Harmonization Act H.R. 3205 - FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 - Humanitarian Device Reform Act H.R. 3208 - Patients Come First Act H.R. 3206 - Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 - Food and Drug Administration Mission Reform Act H.R. 3207 - Modernizing Laboratory Test Standards for Patients Act H.R. 3204 - Guidance Accountability and Transparency Act H.R. 3847 - Safety of Untested and New Devices Act of 2012 H.R. 3975 - A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 H.R. 4056 - Science and Technology Regulatory Relief Act H.R. 5651 - Food and Drug Administration Reform Act 2012 S. 1700 - The Medical Device Regulatory Improvement Act S. 1865 - The Patient Access to Medical Innovation Act S. 1943 - Novel Device Regulatory Relief Act of 2011 S. 1972 - A bill to amend the Food and Drug Administration's mission S. 1995 - A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. S. 2067 - Safe, Transparent, and Efficient Medical Device Act S. 2113 - A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health S. 2193 - Ensuring Safe Medical Devices for Patients S. 3187 - A bill to amend the Federal Food, Drug, and Cosetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes
Keeping America Competitive Through Harmonization Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the medical device regulatory system particularly for Class II devices through the 510(k) system including the following FDA related legislation: H.R. 3209 -Premarket Predictability Act H.R. 3203 -Novel Device Regulatory Relief Act H.R. 3230 -Keeping America Competitive through Harmonization Act H.R. 3205 -FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 -Humanitarian Device Reform Act H.R. 3208 -Patients Come First Act H.R. 3206 -Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 -Food and Drug Administration Mission Reform Act H.R. 3207 -Modernizing Laboratory Test Standards for Patients Act H.R. 3204 -Guidance Accountability and Transparency Act H.R. 3847- Safety of Untested and New Devices Act of 2012 H.R. 3975- A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 H.R. 4056- Science and Technology Regulatory Relief Act H.R. 5651- Food and Drug Administration Reform Act of 2012 S. 1700 -The Medical Device Regulatory Improvement Act S. 1865 -The Patient Access to Medical Innovation Act S. 1943 -Novel Device Regulatory Relief Act of 2011 S. 1972 -A bill to amend the Food and Drug Administration's mission S. 1995 -A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. S. 2067- Safe, Transparent, and Efficient Medical Device Act S.2113- A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health S. 2193- Ensuring Safe Medical Devices for Patients S.3187- A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes
Keeping America Competitive Through Harmonization Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the medical device regulatory system particularly for Class II devices through the 510(k) system including the following FDA related legislation: H.R. 3209 -Premarket Predictability Act H.R. 3203 -Novel Device Regulatory Relief Act H.R. 3230 -Keeping America Competitive through Harmonization Act H.R. 3205 -FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 -Humanitarian Device Reform Act H.R. 3208 -Patients Come First Act H.R. 3206 -Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 -Food and Drug Administration Mission Reform Act H.R. 3207 -Modernizing Laboratory Test Standards for Patients Act H.R. 3204 -Guidance Accountability and Transparency Act H.R. 3847- Safety of Untested and New Devices Act of 2012 H.R. 3975- A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 H.R. 4056- Science and Technology Regulatory Relief Act S. 1700 -The Medical Device Regulatory Improvement Act S. 1865 -The Patient Access to Medical Innovation Act S. 1943 -Novel Device Regulatory Relief Act of 2011 S. 1972 -A bill to amend the Food and Drug Administration's mission S. 1995 -A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. S. 2067- Safe, Transparent, and Efficient Medical Device Act S.2113- A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health S. 2193- Ensuring Safe Medical Devices for Patients Discussion drafts on user fee legislation from the Energy and Commerce Committee and the Health, Education, Labor and Pensions Committee
Keeping America Competitive Through Harmonization Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the FDA medical device regulatory system particularly to promote greater efficiency, transparency, and predictability, particularly through the 510(k) system. The following bills accomplish those goals: H.R. 3209 - Premarket Predicability Act H.R. 3203 - Novel Device Regulatory Relief Act H.R. 3230 - Keeping America Competitive through Harmonization Act H.R. 3205 - FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 - Humanitarian Device Reform Act H.R. 3208 - Patients Come First Act H.R. 3206 - Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 - Food and Drug Administration Mission Reform Act H.R. 3207 - Modernizing Laboratory Test Standards for Patients Act H.R. 3204 - Guidance Accountability and Transparency Act H.R. 3847 - Safety of Untested and New Devices Act of 2012 H.R. 3975 - A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 H.R. 4056 - Science and Technology Regulatory Relief Act H.R. 5651 - Food and Drug Administration Reform Act 2012 S. 1700 - The Medical Device Regulatory Improvement Act S. 1865 - The Patient Access to Medical Innovation Act S. 1943 - Novel Device Regulatory Relief Act of 2011 S. 1972 - A bill to amend the Food and Drug Administration's mission S. 1995 - A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. S. 2067 - Safe, Transparent, and Efficient Medical Device Act S. 2113 - A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health S. 2193 - Ensuring Safe Medical Devices for Patients S. 3187 - A bill to amend the Federal Food, Drug, and Cosetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes
STEM Education Innovation Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
S.758, A bill to establish a Science, Technology, Engineering, and Math (STEM) Master Teacher Corps program S.716, Innovation Inspiration School Grant Program Act- to promote STEM education H.R. 3373- STEM Education Innovation Act- to promote STEM education
STEM Education Innovation Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
S. 758, A bill to establish a Science, Technology, Engineering and Math (STEM) Master Teacher Corps program S. 716, Innovation Inspiration School Grant Program Act - to promote STEM education H.R. 3373 - STEM Education innovation Act - to promote STEM education H.R. 6517 - The STEM Network Act - to promote STEM education
STEM Education Innovation Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
S. 758, A bill to establish a Science, Technology, Engineering, and Math (STEM) Master Teacher Corps program S. 716, Innovation Inspiration School Grant Program Act - to promote STEM education H.R. 3373 - STEM Education Innovation Act - to promote STEM education H.R. 6517 - The STEM Network Act - to promote STEM education
SOUND Devices Act of 2012
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the medical device regulatory system particularly for Class II devices through the 510(k) system including the following FDA related legislation: H.R. 3209 -Premarket Predictability Act H.R. 3203 -Novel Device Regulatory Relief Act H.R. 3230 -Keeping America Competitive through Harmonization Act H.R. 3205 -FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 -Humanitarian Device Reform Act H.R. 3208 -Patients Come First Act H.R. 3206 -Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 -Food and Drug Administration Mission Reform Act H.R. 3207 -Modernizing Laboratory Test Standards for Patients Act H.R. 3204 -Guidance Accountability and Transparency Act H.R. 3847- Safety of Untested and New Devices Act of 2012 H.R. 3975- A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 H.R. 4056- Science and Technology Regulatory Relief Act S. 1700 -The Medical Device Regulatory Improvement Act S. 1865 -The Patient Access to Medical Innovation Act S. 1943 -Novel Device Regulatory Relief Act of 2011 S. 1972 -A bill to amend the Food and Drug Administration's mission S. 1995 -A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. S. 2067- Safe, Transparent, and Efficient Medical Device Act S.2113- A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health S. 2193- Ensuring Safe Medical Devices for Patients Discussion drafts on user fee legislation from the Energy and Commerce Committee and the Health, Education, Labor and Pensions Committee
SOUND Devices Act of 2012
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the medical device regulatory system particularly for Class II devices through the 510(k) system including the following FDA related legislation: H.R. 3209 -Premarket Predictability Act H.R. 3203 -Novel Device Regulatory Relief Act H.R. 3230 -Keeping America Competitive through Harmonization Act H.R. 3205 -FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 -Humanitarian Device Reform Act H.R. 3208 -Patients Come First Act H.R. 3206 -Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 -Food and Drug Administration Mission Reform Act H.R. 3207 -Modernizing Laboratory Test Standards for Patients Act H.R. 3204 -Guidance Accountability and Transparency Act H.R. 3847- Safety of Untested and New Devices Act of 2012 H.R. 3975- A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 H.R. 4056- Science and Technology Regulatory Relief Act H.R. 5651- Food and Drug Administration Reform Act of 2012 S. 1700 -The Medical Device Regulatory Improvement Act S. 1865 -The Patient Access to Medical Innovation Act S. 1943 -Novel Device Regulatory Relief Act of 2011 S. 1972 -A bill to amend the Food and Drug Administration's mission S. 1995 -A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. S. 2067- Safe, Transparent, and Efficient Medical Device Act S.2113- A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health S. 2193- Ensuring Safe Medical Devices for Patients S.3187- A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes
SOUND Devices Act of 2012
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the FDA medical device regulatory system particularly to promote greater efficiency, transparency, and predictability, particularly through the 510(k) system. The following bills accomplish those goals: H.R. 3209 - Premarket Predicability Act H.R. 3203 - Novel Device Regulatory Relief Act H.R. 3230 - Keeping America Competitive through Harmonization Act H.R. 3205 - FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 - Humanitarian Device Reform Act H.R. 3208 - Patients Come First Act H.R. 3206 - Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 - Food and Drug Administration Mission Reform Act H.R. 3207 - Modernizing Laboratory Test Standards for Patients Act H.R. 3204 - Guidance Accountability and Transparency Act H.R. 3847 - Safety of Untested and New Devices Act of 2012 H.R. 3975 - A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 H.R. 4056 - Science and Technology Regulatory Relief Act H.R. 5651 - Food and Drug Administration Reform Act 2012 S. 1700 - The Medical Device Regulatory Improvement Act S. 1865 - The Patient Access to Medical Innovation Act S. 1943 - Novel Device Regulatory Relief Act of 2011 S. 1972 - A bill to amend the Food and Drug Administration's mission S. 1995 - A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. S. 2067 - Safe, Transparent, and Efficient Medical Device Act S. 2113 - A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health S. 2193 - Ensuring Safe Medical Devices for Patients S. 3187 - A bill to amend the Federal Food, Drug, and Cosetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes
Science and Technology Regulatory Relief Act of 2012
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the FDA medical device regulatory system particularly to promote greater efficiency, transparency, and predictability, particularly through the 510(k) system. The following bills accomplish those goals: H.R. 3209 - Premarket Predicability Act H.R. 3203 - Novel Device Regulatory Relief Act H.R. 3230 - Keeping America Competitive through Harmonization Act H.R. 3205 - FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 - Humanitarian Device Reform Act H.R. 3208 - Patients Come First Act H.R. 3206 - Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 - Food and Drug Administration Mission Reform Act H.R. 3207 - Modernizing Laboratory Test Standards for Patients Act H.R. 3204 - Guidance Accountability and Transparency Act H.R. 3847 - Safety of Untested and New Devices Act of 2012 H.R. 3975 - A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 H.R. 4056 - Science and Technology Regulatory Relief Act H.R. 5651 - Food and Drug Administration Reform Act 2012 S. 1700 - The Medical Device Regulatory Improvement Act S. 1865 - The Patient Access to Medical Innovation Act S. 1943 - Novel Device Regulatory Relief Act of 2011 S. 1972 - A bill to amend the Food and Drug Administration's mission S. 1995 - A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. S. 2067 - Safe, Transparent, and Efficient Medical Device Act S. 2113 - A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health S. 2193 - Ensuring Safe Medical Devices for Patients S. 3187 - A bill to amend the Federal Food, Drug, and Cosetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes
Science and Technology Regulatory Relief Act of 2012
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the medical device regulatory system particularly for Class II devices through the 510(k) system including the following FDA related legislation: H.R. 3209 -Premarket Predictability Act H.R. 3203 -Novel Device Regulatory Relief Act H.R. 3230 -Keeping America Competitive through Harmonization Act H.R. 3205 -FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 -Humanitarian Device Reform Act H.R. 3208 -Patients Come First Act H.R. 3206 -Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 -Food and Drug Administration Mission Reform Act H.R. 3207 -Modernizing Laboratory Test Standards for Patients Act H.R. 3204 -Guidance Accountability and Transparency Act H.R. 3847- Safety of Untested and New Devices Act of 2012 H.R. 3975- A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 H.R. 4056- Science and Technology Regulatory Relief Act H.R. 5651- Food and Drug Administration Reform Act of 2012 S. 1700 -The Medical Device Regulatory Improvement Act S. 1865 -The Patient Access to Medical Innovation Act S. 1943 -Novel Device Regulatory Relief Act of 2011 S. 1972 -A bill to amend the Food and Drug Administration's mission S. 1995 -A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. S. 2067- Safe, Transparent, and Efficient Medical Device Act S.2113- A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health S. 2193- Ensuring Safe Medical Devices for Patients S.3187- A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes
Science and Technology Regulatory Relief Act of 2012
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the medical device regulatory system particularly for Class II devices through the 510(k) system including the following FDA related legislation: H.R. 3209 -Premarket Predictability Act H.R. 3203 -Novel Device Regulatory Relief Act H.R. 3230 -Keeping America Competitive through Harmonization Act H.R. 3205 -FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 -Humanitarian Device Reform Act H.R. 3208 -Patients Come First Act H.R. 3206 -Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 -Food and Drug Administration Mission Reform Act H.R. 3207 -Modernizing Laboratory Test Standards for Patients Act H.R. 3204 -Guidance Accountability and Transparency Act H.R. 3847- Safety of Untested and New Devices Act of 2012 H.R. 3975- A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 H.R. 4056- Science and Technology Regulatory Relief Act S. 1700 -The Medical Device Regulatory Improvement Act S. 1865 -The Patient Access to Medical Innovation Act S. 1943 -Novel Device Regulatory Relief Act of 2011 S. 1972 -A bill to amend the Food and Drug Administration's mission S. 1995 -A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. S. 2067- Safe, Transparent, and Efficient Medical Device Act S.2113- A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health S. 2193- Ensuring Safe Medical Devices for Patients Discussion drafts on user fee legislation from the Energy and Commerce Committee and the Health, Education, Labor and Pensions Committee
Health Care Cost Reduction Act of 2012
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
S. 17, the Medical Device and Innovation Protection Act - a bill to repeal the medical device tax S. 262, A bill to repeal the excise tax on medical device manufacturers H.R. 436, the Protect Medical Innovation Act - a bill to repeal the medical device tax H.R. 734, To amend the Internal Revenue Code of 1986 to repeal the medical device tax; H.R. 488, Save Our Medical Devices Act of 2011 - a bill to repeal the medical device tax H.R. 942, American Research and Competitiveness Act of 2011 - a bill to extend the research credit through 2012 S. 239, the Innovate America Act, a bill to support innovation through tax credits such as research and development S. 1866, the Agree Act which calls for an increase in the rate of the alternative simplified research tax credit and makes such credit permanent Corporate tax reform - specifically the treatment of international earnings including the Chairman's International Tax Reform discussion draft
Health Care Cost Reduction Act of 2012
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
S.17, the Medical Device Access and Innovation Protection Act- a bill to repeal the medical device tax S.262, A bill to repeal the excise tax on medical device manufacturers H.R. 436, the Protect Medical Innovation Act- a bill to repeal the medical device tax H.R. 734, To amend the Internal Revenue Code of 1986 to repeal the medical device tax; H.R. 488, Save Our Medical Devices Act of 2011- a bill to repeal the medical device tax H.R. 942, American Research and Competitiveness Act of 2011- a bill to extend the research credit through 2012 S. 239, the Innovate America Act, a bill to support innovation through tax credits such as research and development S. 1866, the Agree Act which calls for an increase in the rate of the alternative simplified research tax credit and makes such credit permanent Corporate tax reform- specifically the treatment of international earnings including the Chairman's International Tax Reform discussion draft
Health Care Cost Reduction Act of 2012
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
S.17, the Medical Device Access and Innovation Protection Act- a bill to repeal the medical device tax S.262, A bill to repeal the excise tax on medical device manufacturers H.R. 436, the Protect Medical Innovation Act- a bill to repeal the medical device tax H.R. 734, To amend the Internal Revenue Code of 1986 to repeal the medical device tax; H.R. 488, Save Our Medical Devices Act of 2011- a bill to repeal the medical device tax H.R. 942, American Research and Competitiveness Act of 2011- a bill to extend the research credit through 2012 S. 239, the Innovate America Act, a bill to support innovation through tax credits such as research and development S. 1866, the Agree Act which calls for an increase in the rate of the alternative simplified research tax credit and makes such credit permanent Corporate tax reform- specifically the treatment of international earnings including the Chairman's International Tax Reform discussion draft
Health Care Cost Reduction Act of 2012
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
S.17, the Medical Device and Innovation Protection Act - a bill to repeal the medical device tax S. 262, A bill to repeal the excise tax on medical device manufacturers H.R. 436, the Protect Medical Innovation Act - a bill to repeal the medical device tax H.R. 734, To amend the Internal Revenue Code of 1986 to repeal the medical device tax; H.R.488, Save Our Medical Devices Act of 2011 - a bill to repeal the medical device tax H.R. 942, American Research and Competitiveness Act of 2011 - a bill to extend the research credit through 2012 S.239, the Innovate America Act, a bill to support innovation through tax credits such as research and development S. 1866, the Agree Act which calls for an increase in the rate of hte alternative simplified research tax credit and makes such credit permanent Corporate tax reform - specifically the treatment of international earnings including the Chairman's International Tax Reform
Save Our Medical Devices Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
S.17, the Medical Device and Innovation Protection Act - a bill to repeal the medical device tax S. 262, A bill to repeal the excise tax on medical device manufacturers H.R. 436, the Protect Medical Innovation Act - a bill to repeal the medical device tax H.R. 734, To amend the Internal Revenue Code of 1986 to repeal the medical device tax; H.R.488, Save Our Medical Devices Act of 2011 - a bill to repeal the medical device tax H.R. 942, American Research and Competitiveness Act of 2011 - a bill to extend the research credit through 2012 S.239, the Innovate America Act, a bill to support innovation through tax credits such as research and development S. 1866, the Agree Act which calls for an increase in the rate of hte alternative simplified research tax credit and makes such credit permanent Corporate tax reform - specifically the treatment of international earnings including the Chairman's International Tax Reform
Save Our Medical Devices Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
S.17, the Medical Device Access and Innovation Protection Act- a bill to repeal the medical device tax S.262, A bill to repeal the excise tax on medical device manufacturers H.R. 436, the Protect Medical Innovation Act- a bill to repeal the medical device tax H.R. 734, To amend the Internal Revenue Code of 1986 to repeal the medical device tax; H.R. 488, Save Our Medical Devices Act of 2011- a bill to repeal the medical device tax H.R. 942, American Research and Competitiveness Act of 2011- a bill to extend the research credit through 2012 S. 239, the Innovate America Act, a bill to support innovation through tax credits such as research and development S. 1866, the Agree Act which calls for an increase in the rate of the alternative simplified research tax credit and makes such credit permanent Corporate tax reform- specifically the treatment of international earnings including the Chairman's International Tax Reform discussion draft
Save Our Medical Devices Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
S. 17, the Medical Device and Innovation Protection Act - a bill to repeal the medical device tax S. 262, A bill to repeal the excise tax on medical device manufacturers H.R. 436, the Protect Medical Innovation Act - a bill to repeal the medical device tax H.R. 734, To amend the Internal Revenue Code of 1986 to repeal the medical device tax; H.R. 488, Save Our Medical Devices Act of 2011 - a bill to repeal the medical device tax H.R. 942, American Research and Competitiveness Act of 2011 - a bill to extend the research credit through 2012 S. 239, the Innovate America Act, a bill to support innovation through tax credits such as research and development S. 1866, the Agree Act which calls for an increase in the rate of the alternative simplified research tax credit and makes such credit permanent Corporate tax reform - specifically the treatment of international earnings including the Chairman's International Tax Reform discussion draft
Save Our Medical Devices Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
S.17, the Medical Device Access and Innovation Protection Act- a bill to repeal the medical device tax S.262, A bill to repeal the excise tax on medical device manufacturers H.R. 436, the Protect Medical Innovation Act- a bill to repeal the medical device tax H.R. 734, To amend the Internal Revenue Code of 1986 to repeal the medical device tax; H.R. 488, Save Our Medical Devices Act of 2011- a bill to repeal the medical device tax H.R. 942, American Research and Competitiveness Act of 2011- a bill to extend the research credit through 2012 S. 239, the Innovate America Act, a bill to support innovation through tax credits such as research and development S. 1866, the Agree Act which calls for an increase in the rate of the alternative simplified research tax credit and makes such credit permanent Corporate tax reform- specifically the treatment of international earnings including the Chairman's International Tax Reform discussion draft
Food and Drug Administration Reform Act of 2012
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the FDA medical device regulatory system particularly to promote greater efficiency, transparency, and predictability, particularly through the 510(k) system. The following bills accomplish those goals: H.R. 3209 - Premarket Predicability Act H.R. 3203 - Novel Device Regulatory Relief Act H.R. 3230 - Keeping America Competitive through Harmonization Act H.R. 3205 - FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 - Humanitarian Device Reform Act H.R. 3208 - Patients Come First Act H.R. 3206 - Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 - Food and Drug Administration Mission Reform Act H.R. 3207 - Modernizing Laboratory Test Standards for Patients Act H.R. 3204 - Guidance Accountability and Transparency Act H.R. 3847 - Safety of Untested and New Devices Act of 2012 H.R. 3975 - A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 H.R. 4056 - Science and Technology Regulatory Relief Act H.R. 5651 - Food and Drug Administration Reform Act 2012 S. 1700 - The Medical Device Regulatory Improvement Act S. 1865 - The Patient Access to Medical Innovation Act S. 1943 - Novel Device Regulatory Relief Act of 2011 S. 1972 - A bill to amend the Food and Drug Administration's mission S. 1995 - A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. S. 2067 - Safe, Transparent, and Efficient Medical Device Act S. 2113 - A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health S. 2193 - Ensuring Safe Medical Devices for Patients S. 3187 - A bill to amend the Federal Food, Drug, and Cosetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes
Food and Drug Administration Reform Act of 2012
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination H.R. 5651 - Food and Drug Administration Reform Act 2012 - A bill to renew the FDA User Fee program and to reform the medical device review program. S. 3187 - FDA Safety and Innovation Act - A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes. Senate draft legislation to establish a national track and trace system for pharmaceuticals, specifically relating to convenience kits
Food and Drug Administration Reform Act of 2012
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the medical device regulatory system particularly for Class II devices through the 510(k) system including the following FDA related legislation: H.R. 3209 -Premarket Predictability Act H.R. 3203 -Novel Device Regulatory Relief Act H.R. 3230 -Keeping America Competitive through Harmonization Act H.R. 3205 -FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 -Humanitarian Device Reform Act H.R. 3208 -Patients Come First Act H.R. 3206 -Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 -Food and Drug Administration Mission Reform Act H.R. 3207 -Modernizing Laboratory Test Standards for Patients Act H.R. 3204 -Guidance Accountability and Transparency Act H.R. 3847- Safety of Untested and New Devices Act of 2012 H.R. 3975- A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 H.R. 4056- Science and Technology Regulatory Relief Act H.R. 5651- Food and Drug Administration Reform Act of 2012 S. 1700 -The Medical Device Regulatory Improvement Act S. 1865 -The Patient Access to Medical Innovation Act S. 1943 -Novel Device Regulatory Relief Act of 2011 S. 1972 -A bill to amend the Food and Drug Administration's mission S. 1995 -A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. S. 2067- Safe, Transparent, and Efficient Medical Device Act S.2113- A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health S. 2193- Ensuring Safe Medical Devices for Patients S.3187- A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Appropriations for the Food and Drug Administration, particularly the Center for Devices and Radiological Health Appropriations for pain management awareness programs HR5973 Agriculture, Rural Development, FDA & Related Agencies Appropriations Act 2013 S. 2375 Agriculture, Rural Development, FDA & Related Agencies Appropriations Act 2013
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Appropriations for pain management awareness programs H.R. 5973 Agriculture, Rural Development, FDA & Related Agencies Appropriations Act 2013 S. 2375 Agriculture, Rural Development, FDA & Related Agencies Appropriations Act 2013 H.J. Res. 117 - Continuing Appropriations Act - provisions related to user fees for FDA
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Appropriations for the Food and Drug Administration, particularly the Center for Devices and Radiological Health Appropriations for pain management awareness programs H.R. 5973 Agriculture, Rural Development, FDA & Related Agencies Appropriations Act 2013 S. 2375 Agriculture, Rural Development, FDA & Related Agencies Appropriations Act 2013 H.J. Res. 117 - Continuing Appropriations Act - provisions related to user fees for FDA
STEM Network Act
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
S. 758, A bill to establish a Science, Technology, Engineering and Math (STEM) Master Teacher Corps program S. 716, Innovation Inspiration School Grant Program Act - to promote STEM education H.R. 3373 - STEM Education innovation Act - to promote STEM education H.R. 6517 - The STEM Network Act - to promote STEM education
STEM Network Act
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
S. 758, A bill to establish a Science, Technology, Engineering, and Math (STEM) Master Teacher Corps program S. 716, Innovation Inspiration School Grant Program Act - to promote STEM education H.R. 3373 - STEM Education Innovation Act - to promote STEM education H.R. 6517 - The STEM Network Act - to promote STEM education
To amend the Internal Revenue Code of 1986 to repeal the medical device tax, and for other purposes.
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
S.17, the Medical Device Access and Innovation Protection Act- a bill to repeal the medical device tax S.262, A bill to repeal the excise tax on medical device manufacturers H.R. 436, the Protect Medical Innovation Act- a bill to repeal the medical device tax H.R. 734, To amend the Internal Revenue Code of 1986 to repeal the medical device tax; H.R. 488, Save Our Medical Devices Act of 2011- a bill to repeal the medical device tax H.R. 942, American Research and Competitiveness Act of 2011- a bill to extend the research credit through 2012 S. 239, the Innovate America Act, a bill to support innovation through tax credits such as research and development S. 1866, the Agree Act which calls for an increase in the rate of the alternative simplified research tax credit and makes such credit permanent Corporate tax reform- specifically the treatment of international earnings including the Chairman's International Tax Reform discussion draft
To amend the Internal Revenue Code of 1986 to repeal the medical device tax, and for other purposes.
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
S.17, the Medical Device Access and Innovation Protection Act- a bill to repeal the medical device tax S.262, A bill to repeal the excise tax on medical device manufacturers H.R. 436, the Protect Medical Innovation Act- a bill to repeal the medical device tax H.R. 734, To amend the Internal Revenue Code of 1986 to repeal the medical device tax; H.R. 488, Save Our Medical Devices Act of 2011- a bill to repeal the medical device tax H.R. 942, American Research and Competitiveness Act of 2011- a bill to extend the research credit through 2012 S. 239, the Innovate America Act, a bill to support innovation through tax credits such as research and development S. 1866, the Agree Act which calls for an increase in the rate of the alternative simplified research tax credit and makes such credit permanent Corporate tax reform- specifically the treatment of international earnings including the Chairman's International Tax Reform discussion draft
To amend the Internal Revenue Code of 1986 to repeal the medical device tax, and for other purposes.
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
S. 17, the Medical Device and Innovation Protection Act - a bill to repeal the medical device tax S. 262, A bill to repeal the excise tax on medical device manufacturers H.R. 436, the Protect Medical Innovation Act - a bill to repeal the medical device tax H.R. 734, To amend the Internal Revenue Code of 1986 to repeal the medical device tax; H.R. 488, Save Our Medical Devices Act of 2011 - a bill to repeal the medical device tax H.R. 942, American Research and Competitiveness Act of 2011 - a bill to extend the research credit through 2012 S. 239, the Innovate America Act, a bill to support innovation through tax credits such as research and development S. 1866, the Agree Act which calls for an increase in the rate of the alternative simplified research tax credit and makes such credit permanent Corporate tax reform - specifically the treatment of international earnings including the Chairman's International Tax Reform discussion draft
To amend the Internal Revenue Code of 1986 to repeal the medical device tax, and for other purposes.
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
S.17, the Medical Device and Innovation Protection Act - a bill to repeal the medical device tax S. 262, A bill to repeal the excise tax on medical device manufacturers H.R. 436, the Protect Medical Innovation Act - a bill to repeal the medical device tax H.R. 734, To amend the Internal Revenue Code of 1986 to repeal the medical device tax; H.R.488, Save Our Medical Devices Act of 2011 - a bill to repeal the medical device tax H.R. 942, American Research and Competitiveness Act of 2011 - a bill to extend the research credit through 2012 S.239, the Innovate America Act, a bill to support innovation through tax credits such as research and development S. 1866, the Agree Act which calls for an increase in the rate of hte alternative simplified research tax credit and makes such credit permanent Corporate tax reform - specifically the treatment of international earnings including the Chairman's International Tax Reform
American Research and Competitiveness Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
S.17, the Medical Device and Innovation Protection Act - a bill to repeal the medical device tax S. 262, A bill to repeal the excise tax on medical device manufacturers H.R. 436, the Protect Medical Innovation Act - a bill to repeal the medical device tax H.R. 734, To amend the Internal Revenue Code of 1986 to repeal the medical device tax; H.R.488, Save Our Medical Devices Act of 2011 - a bill to repeal the medical device tax H.R. 942, American Research and Competitiveness Act of 2011 - a bill to extend the research credit through 2012 S.239, the Innovate America Act, a bill to support innovation through tax credits such as research and development S. 1866, the Agree Act which calls for an increase in the rate of hte alternative simplified research tax credit and makes such credit permanent Corporate tax reform - specifically the treatment of international earnings including the Chairman's International Tax Reform
American Research and Competitiveness Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
S.17, the Medical Device Access and Innovation Protection Act- a bill to repeal the medical device tax S.262, A bill to repeal the excise tax on medical device manufacturers H.R. 436, the Protect Medical Innovation Act- a bill to repeal the medical device tax H.R. 734, To amend the Internal Revenue Code of 1986 to repeal the medical device tax; H.R. 488, Save Our Medical Devices Act of 2011- a bill to repeal the medical device tax H.R. 942, American Research and Competitiveness Act of 2011- a bill to extend the research credit through 2012 S. 239, the Innovate America Act, a bill to support innovation through tax credits such as research and development S. 1866, the Agree Act which calls for an increase in the rate of the alternative simplified research tax credit and makes such credit permanent Corporate tax reform- specifically the treatment of international earnings including the Chairman's International Tax Reform discussion draft
American Research and Competitiveness Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
S.17, the Medical Device Access and Innovation Protection Act- a bill to repeal the medical device tax S.262, A bill to repeal the excise tax on medical device manufacturers H.R. 436, the Protect Medical Innovation Act- a bill to repeal the medical device tax H.R. 734, To amend the Internal Revenue Code of 1986 to repeal the medical device tax; H.R. 488, Save Our Medical Devices Act of 2011- a bill to repeal the medical device tax H.R. 942, American Research and Competitiveness Act of 2011- a bill to extend the research credit through 2012 S. 239, the Innovate America Act, a bill to support innovation through tax credits such as research and development S. 1866, the Agree Act which calls for an increase in the rate of the alternative simplified research tax credit and makes such credit permanent Corporate tax reform- specifically the treatment of international earnings including the Chairman's International Tax Reform discussion draft
American Research and Competitiveness Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
S. 17, the Medical Device and Innovation Protection Act - a bill to repeal the medical device tax S. 262, A bill to repeal the excise tax on medical device manufacturers H.R. 436, the Protect Medical Innovation Act - a bill to repeal the medical device tax H.R. 734, To amend the Internal Revenue Code of 1986 to repeal the medical device tax; H.R. 488, Save Our Medical Devices Act of 2011 - a bill to repeal the medical device tax H.R. 942, American Research and Competitiveness Act of 2011 - a bill to extend the research credit through 2012 S. 239, the Innovate America Act, a bill to support innovation through tax credits such as research and development S. 1866, the Agree Act which calls for an increase in the rate of the alternative simplified research tax credit and makes such credit permanent Corporate tax reform - specifically the treatment of international earnings including the Chairman's International Tax Reform discussion draft
Health Insurance Affordability Act of 2007
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the medical device regulatory system particularly for Class II devices through the 510(k) system including the following FDA related legislation: H.R. 3209 -Premarket Predictability Act H.R. 3203 -Novel Device Regulatory Relief Act H.R. 3230 -Keeping America Competitive through Harmonization Act H.R. 3205 -FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 -Humanitarian Device Reform Act H.R. 3208 -Patients Come First Act H.R. 3206 -Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 -Food and Drug Administration Mission Reform Act H.R. 3207 -Modernizing Laboratory Test Standards for Patients Act H.R. 3204 -Guidance Accountability and Transparency Act H.R. 3847- Safety of Untested and New Devices Act of 2012 H.R. 3975- A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 H.R. 4056- Science and Technology Regulatory Relief Act S. 1700 -The Medical Device Regulatory Improvement Act S. 1865 -The Patient Access to Medical Innovation Act S. 1943 -Novel Device Regulatory Relief Act of 2011 S. 1972 -A bill to amend the Food and Drug Administration's mission S. 1995 -A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. S. 2067- Safe, Transparent, and Efficient Medical Device Act S.2113- A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health S. 2193- Ensuring Safe Medical Devices for Patients Discussion drafts on user fee legislation from the Energy and Commerce Committee and the Health, Education, Labor and Pensions Committee
Health Insurance Affordability Act of 2007
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the FDA medical device regulatory system particularly to promote greater efficiency, transparency, and predictability, particularly through the 510(k) system. The following bills accomplish those goals: H.R. 3209 - Premarket Predicability Act H.R. 3203 - Novel Device Regulatory Relief Act H.R. 3230 - Keeping America Competitive through Harmonization Act H.R. 3205 - FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 - Humanitarian Device Reform Act H.R. 3208 - Patients Come First Act H.R. 3206 - Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 - Food and Drug Administration Mission Reform Act H.R. 3207 - Modernizing Laboratory Test Standards for Patients Act H.R. 3204 - Guidance Accountability and Transparency Act H.R. 3847 - Safety of Untested and New Devices Act of 2012 H.R. 3975 - A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 H.R. 4056 - Science and Technology Regulatory Relief Act H.R. 5651 - Food and Drug Administration Reform Act 2012 S. 1700 - The Medical Device Regulatory Improvement Act S. 1865 - The Patient Access to Medical Innovation Act S. 1943 - Novel Device Regulatory Relief Act of 2011 S. 1972 - A bill to amend the Food and Drug Administration's mission S. 1995 - A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. S. 2067 - Safe, Transparent, and Efficient Medical Device Act S. 2113 - A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health S. 2193 - Ensuring Safe Medical Devices for Patients S. 3187 - A bill to amend the Federal Food, Drug, and Cosetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes
Health Insurance Affordability Act of 2007
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the medical device regulatory system particularly for Class II devices through the 510(k) system including the following FDA related legislation: H.R. 3209 -Premarket Predictability Act H.R. 3203 -Novel Device Regulatory Relief Act H.R. 3230 -Keeping America Competitive through Harmonization Act H.R. 3205 -FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 -Humanitarian Device Reform Act H.R. 3208 -Patients Come First Act H.R. 3206 -Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 -Food and Drug Administration Mission Reform Act H.R. 3207 -Modernizing Laboratory Test Standards for Patients Act H.R. 3204 -Guidance Accountability and Transparency Act H.R. 3847- Safety of Untested and New Devices Act of 2012 H.R. 3975- A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 H.R. 4056- Science and Technology Regulatory Relief Act H.R. 5651- Food and Drug Administration Reform Act of 2012 S. 1700 -The Medical Device Regulatory Improvement Act S. 1865 -The Patient Access to Medical Innovation Act S. 1943 -Novel Device Regulatory Relief Act of 2011 S. 1972 -A bill to amend the Food and Drug Administration's mission S. 1995 -A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. S. 2067- Safe, Transparent, and Efficient Medical Device Act S.2113- A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health S. 2193- Ensuring Safe Medical Devices for Patients S.3187- A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes
Novel Device Regulatory Relief Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the medical device regulatory system particularly for Class II devices through the 510(k) system including the following FDA related legislation: H.R. 3209 -Premarket Predictability Act H.R. 3203 -Novel Device Regulatory Relief Act H.R. 3230 -Keeping America Competitive through Harmonization Act H.R. 3205 -FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 -Humanitarian Device Reform Act H.R. 3208 -Patients Come First Act H.R. 3206 -Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 -Food and Drug Administration Mission Reform Act H.R. 3207 -Modernizing Laboratory Test Standards for Patients Act H.R. 3204 -Guidance Accountability and Transparency Act S. 1700 -The Medical Device Regulatory Improvement Act S. 1865 -The Patient Access to Medical Innovation Act S. 1943 -Novel Device Regulatory Relief Act of 2011 S. 1972 -A bill to amend the Food and Drug Administration's mission S. 1995 -A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes.
Guidance Accountability and Transparency Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the medical device regulatory system particularly for Class II devices through the 510(k) system including the following FDA related legislation: H.R. 3209 -Premarket Predictability Act H.R. 3203 -Novel Device Regulatory Relief Act H.R. 3230 -Keeping America Competitive through Harmonization Act H.R. 3205 -FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 -Humanitarian Device Reform Act H.R. 3208 -Patients Come First Act H.R. 3206 -Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 -Food and Drug Administration Mission Reform Act H.R. 3207 -Modernizing Laboratory Test Standards for Patients Act H.R. 3204 -Guidance Accountability and Transparency Act S. 1700 -The Medical Device Regulatory Improvement Act S. 1865 -The Patient Access to Medical Innovation Act S. 1943 -Novel Device Regulatory Relief Act of 2011 S. 1972 -A bill to amend the Food and Drug Administration's mission S. 1995 -A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes.
FDA Renewing Efficiency From Outside Reviewer Management Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the medical device regulatory system particularly for Class II devices through the 510(k) system including the following FDA related legislation: H.R. 3209 -Premarket Predictability Act H.R. 3203 -Novel Device Regulatory Relief Act H.R. 3230 -Keeping America Competitive through Harmonization Act H.R. 3205 -FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 -Humanitarian Device Reform Act H.R. 3208 -Patients Come First Act H.R. 3206 -Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 -Food and Drug Administration Mission Reform Act H.R. 3207 -Modernizing Laboratory Test Standards for Patients Act H.R. 3204 -Guidance Accountability and Transparency Act S. 1700 -The Medical Device Regulatory Improvement Act S. 1865 -The Patient Access to Medical Innovation Act S. 1943 -Novel Device Regulatory Relief Act of 2011 S. 1972 -A bill to amend the Food and Drug Administration's mission S. 1995 -A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes.
Cultivating Scientific Expertise to Foster Innovation for Patients Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the medical device regulatory system particularly for Class II devices through the 510(k) system including the following FDA related legislation: H.R. 3209 -Premarket Predictability Act H.R. 3203 -Novel Device Regulatory Relief Act H.R. 3230 -Keeping America Competitive through Harmonization Act H.R. 3205 -FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 -Humanitarian Device Reform Act H.R. 3208 -Patients Come First Act H.R. 3206 -Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 -Food and Drug Administration Mission Reform Act H.R. 3207 -Modernizing Laboratory Test Standards for Patients Act H.R. 3204 -Guidance Accountability and Transparency Act S. 1700 -The Medical Device Regulatory Improvement Act S. 1865 -The Patient Access to Medical Innovation Act S. 1943 -Novel Device Regulatory Relief Act of 2011 S. 1972 -A bill to amend the Food and Drug Administration's mission S. 1995 -A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the medical device regulatory system particularly for Class II devices through the 510(k) system including the following FDA related legislation: H.R. 3209 -Premarket Predictability Act H.R. 3203 -Novel Device Regulatory Relief Act H.R. 3230 -Keeping America Competitive through Harmonization Act H.R. 3205 -FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 -Humanitarian Device Reform Act H.R. 3208 -Patients Come First Act H.R. 3206 -Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 -Food and Drug Administration Mission Reform Act H.R. 3207 -Modernizing Laboratory Test Standards for Patients Act H.R. 3204 -Guidance Accountability and Transparency Act S. 1700 -The Medical Device Regulatory Improvement Act S. 1865 -The Patient Access to Medical Innovation Act S. 1943 -Novel Device Regulatory Relief Act of 2011 S. 1972 -A bill to amend the Food and Drug Administration's mission S. 1995 -A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes.
Patients Come First Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the medical device regulatory system particularly for Class II devices through the 510(k) system including the following FDA related legislation: H.R. 3209 -Premarket Predictability Act H.R. 3203 -Novel Device Regulatory Relief Act H.R. 3230 -Keeping America Competitive through Harmonization Act H.R. 3205 -FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 -Humanitarian Device Reform Act H.R. 3208 -Patients Come First Act H.R. 3206 -Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 -Food and Drug Administration Mission Reform Act H.R. 3207 -Modernizing Laboratory Test Standards for Patients Act H.R. 3204 -Guidance Accountability and Transparency Act S. 1700 -The Medical Device Regulatory Improvement Act S. 1865 -The Patient Access to Medical Innovation Act S. 1943 -Novel Device Regulatory Relief Act of 2011 S. 1972 -A bill to amend the Food and Drug Administration's mission S. 1995 -A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes.
Premarket Predictability Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the medical device regulatory system particularly for Class II devices through the 510(k) system including the following FDA related legislation: H.R. 3209 -Premarket Predictability Act H.R. 3203 -Novel Device Regulatory Relief Act H.R. 3230 -Keeping America Competitive through Harmonization Act H.R. 3205 -FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 -Humanitarian Device Reform Act H.R. 3208 -Patients Come First Act H.R. 3206 -Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 -Food and Drug Administration Mission Reform Act H.R. 3207 -Modernizing Laboratory Test Standards for Patients Act H.R. 3204 -Guidance Accountability and Transparency Act S. 1700 -The Medical Device Regulatory Improvement Act S. 1865 -The Patient Access to Medical Innovation Act S. 1943 -Novel Device Regulatory Relief Act of 2011 S. 1972 -A bill to amend the Food and Drug Administration's mission S. 1995 -A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes.
Humanitarian Device Reform Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the medical device regulatory system particularly for Class II devices through the 510(k) system including the following FDA related legislation: H.R. 3209 -Premarket Predictability Act H.R. 3203 -Novel Device Regulatory Relief Act H.R. 3230 -Keeping America Competitive through Harmonization Act H.R. 3205 -FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 -Humanitarian Device Reform Act H.R. 3208 -Patients Come First Act H.R. 3206 -Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 -Food and Drug Administration Mission Reform Act H.R. 3207 -Modernizing Laboratory Test Standards for Patients Act H.R. 3204 -Guidance Accountability and Transparency Act S. 1700 -The Medical Device Regulatory Improvement Act S. 1865 -The Patient Access to Medical Innovation Act S. 1943 -Novel Device Regulatory Relief Act of 2011 S. 1972 -A bill to amend the Food and Drug Administration's mission S. 1995 -A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes.
Food and Drug Administration Mission Reform Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the medical device regulatory system particularly for Class II devices through the 510(k) system including the following FDA related legislation: H.R. 3209 -Premarket Predictability Act H.R. 3203 -Novel Device Regulatory Relief Act H.R. 3230 -Keeping America Competitive through Harmonization Act H.R. 3205 -FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 -Humanitarian Device Reform Act H.R. 3208 -Patients Come First Act H.R. 3206 -Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 -Food and Drug Administration Mission Reform Act H.R. 3207 -Modernizing Laboratory Test Standards for Patients Act H.R. 3204 -Guidance Accountability and Transparency Act S. 1700 -The Medical Device Regulatory Improvement Act S. 1865 -The Patient Access to Medical Innovation Act S. 1943 -Novel Device Regulatory Relief Act of 2011 S. 1972 -A bill to amend the Food and Drug Administration's mission S. 1995 -A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes.
Keeping America Competitive Through Harmonization Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the medical device regulatory system particularly for Class II devices through the 510(k) system including the following FDA related legislation: H.R. 3209 -Premarket Predictability Act H.R. 3203 -Novel Device Regulatory Relief Act H.R. 3230 -Keeping America Competitive through Harmonization Act H.R. 3205 -FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 -Humanitarian Device Reform Act H.R. 3208 -Patients Come First Act H.R. 3206 -Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 -Food and Drug Administration Mission Reform Act H.R. 3207 -Modernizing Laboratory Test Standards for Patients Act H.R. 3204 -Guidance Accountability and Transparency Act S. 1700 -The Medical Device Regulatory Improvement Act S. 1865 -The Patient Access to Medical Innovation Act S. 1943 -Novel Device Regulatory Relief Act of 2011 S. 1972 -A bill to amend the Food and Drug Administration's mission S. 1995 -A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes.
Health Care Cost Reduction Act of 2012
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
S.17, the Medical Device Access and Innovation Protection Act- a bill to repeal the medical device tax S.262, A bill to repeal the excise tax on medical device manufacturers H.R. 436, the Protect Medical Innovation Act- a bill to repeal the medical device tax H.R. 734, To amend the Internal Revenue Code of 1986 to repeal the medical device tax; H.R. 488, Save Our Medical Devices Act of 2011- a bill to repeal the medical device tax H.R. 942, American Research and Competitiveness Act of 2011- a bill to extend the research credit through 2012 S. 239, the Innovate America Act, a bill to support innovation through tax credits such as research and development
Health Care Cost Reduction Act of 2012
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
S.17, the Medical Device Access and Innovation Protection Act- a bill to repeal the medical device tax S.262, A bill to repeal the excise tax on medical device manufacturers H.R. 436, the Protect Medical Innovation Act- a bill to repeal the medical device tax H.R. 734, To amend the Internal Revenue Code of 1986 to repeal the medical device tax; H.R. 488, Save Our Medical Devices Act of 2011- a bill to repeal the medical device tax H.R. 942, American Research and Competitiveness Act of 2011- a bill to extend the research credit through 2012 S. 239, the Innovate America Act, a bill to support innovation through tax credits such as research and development S. 1866, the Agree Act which calls for an increase in the rate of the alternative simplified research tax credit and makes such credit permanent Corporate tax reform- specifically the treatment of international earnings including the Chairman's International Tax Reform discussion draft
Health Care Cost Reduction Act of 2012
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
S.17, the Medical Device Access and Innovation Protection Act- a bill to repeal the medical device tax S.262, A bill to repeal the excise tax on medical device manufacturers H.R. 436, the Protect Medical Innovation Act- a bill to repeal the medical device tax H.R. 734, To amend the Internal Revenue Code of 1986 to repeal the medical device tax; H.R. 488, Save Our Medical Devices Act of 2011- a bill to repeal the medical device tax H.R. 942, American Research and Competitiveness Act of 2011- a bill to extend the research credit through 2012 S. 239, the Innovate America Act, a bill to support innovation through tax credits such as research and development Corporate tax reform- specifically the treatment of international earnings
Health Care Cost Reduction Act of 2012
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
S.17, the Medical Device Access and Innovation Protection Act- a bill to repeal the medical device tax S.262, A bill to repeal the excise tax on medical device manufacturers H.R. 436, the Protect Medical Innovation Act- a bill to repeal the medical device tax H.R. 734, To amend the Internal Revenue Code of 1986 to repeal the medical device tax; H.R. 488, Save Our Medical Devices Act of 2011- a bill to repeal the medical device tax H.R. 942, American Research and Competitiveness Act of 2011- a bill to extend the research credit through 2012 S. 239, the Innovate America Act, a bill to support innovation through tax credits such as research and development Corporate tax reform- specifically the treatment of international earnings
Save Our Medical Devices Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
S.17, the Medical Device Access and Innovation Protection Act- a bill to repeal the medical device tax S.262, A bill to repeal the excise tax on medical device manufacturers H.R. 436, the Protect Medical Innovation Act- a bill to repeal the medical device tax H.R. 734, To amend the Internal Revenue Code of 1986 to repeal the medical device tax; H.R. 488, Save Our Medical Devices Act of 2011- a bill to repeal the medical device tax H.R. 942, American Research and Competitiveness Act of 2011- a bill to extend the research credit through 2012 S. 239, the Innovate America Act, a bill to support innovation through tax credits such as research and development
Save Our Medical Devices Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
S.17, the Medical Device Access and Innovation Protection Act- a bill to repeal the medical device tax S.262, A bill to repeal the excise tax on medical device manufacturers H.R. 436, the Protect Medical Innovation Act- a bill to repeal the medical device tax H.R. 734, To amend the Internal Revenue Code of 1986 to repeal the medical device tax; H.R. 488, Save Our Medical Devices Act of 2011- a bill to repeal the medical device tax H.R. 942, American Research and Competitiveness Act of 2011- a bill to extend the research credit through 2012 S. 239, the Innovate America Act, a bill to support innovation through tax credits such as research and development S. 1866, the Agree Act which calls for an increase in the rate of the alternative simplified research tax credit and makes such credit permanent Corporate tax reform- specifically the treatment of international earnings including the Chairman's International Tax Reform discussion draft
Save Our Medical Devices Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
S.17, the Medical Device Access and Innovation Protection Act- a bill to repeal the medical device tax S.262, A bill to repeal the excise tax on medical device manufacturers H.R. 436, the Protect Medical Innovation Act- a bill to repeal the medical device tax H.R. 734, To amend the Internal Revenue Code of 1986 to repeal the medical device tax; H.R. 488, Save Our Medical Devices Act of 2011- a bill to repeal the medical device tax H.R. 942, American Research and Competitiveness Act of 2011- a bill to extend the research credit through 2012 S. 239, the Innovate America Act, a bill to support innovation through tax credits such as research and development Corporate tax reform- specifically the treatment of international earnings
Save Our Medical Devices Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
S.17, the Medical Device Access and Innovation Protection Act- a bill to repeal the medical device tax S.262, A bill to repeal the excise tax on medical device manufacturers H.R. 436, the Protect Medical Innovation Act- a bill to repeal the medical device tax H.R. 734, To amend the Internal Revenue Code of 1986 to repeal the medical device tax; H.R. 488, Save Our Medical Devices Act of 2011- a bill to repeal the medical device tax H.R. 942, American Research and Competitiveness Act of 2011- a bill to extend the research credit through 2012 S. 239, the Innovate America Act, a bill to support innovation through tax credits such as research and development Corporate tax reform- specifically the treatment of international earnings
Strengthening Medicare Anti-Fraud Measures Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
S.454, Strengthening Program Integrity and Accountability in Health Care Act of 2011, a bill to prevent fraud, waste, and abuse under Medicare, Medicaid, and CHIP, and for other purposes H.R. 675, Strengthening Medicare Anti-Fraud Measures Act of 2011, to expand the permissive exclusion from participation in Federal health care programs to individuals and entities affiliated with sanctioned entities
Strengthening Medicare Anti-Fraud Measures Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
S.454, Strengthening Program Integrity and Accountability in Health Care Act of 2011, a bill to prevent fraud, waste, and abuse under Medicare, Medicaid, and CHIP, and for other purposes H.R. 675, Strengthening Medicare Anti-Fraud Measures Act of 2011, to expand the permissive exclusion from participation in Federal health care programs to individuals and entities affiliated with sanctioned entities
Strengthening Medicare Anti-Fraud Measures Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
S.454, Strengthening Program Integrity and Accountability in Health Care Act of 2011, a bill to prevent fraud, waste, and abuse under Medicare, Medicaid, and CHIP, and for other purposes H.R. 675, Strengthening Medicare Anti-Fraud Measures Act of 2011, to expand the permissive exclusion from participation in Federal health care programs to individuals and entities affiliated with sanctioned entities
Strengthening Medicare Anti-Fraud Measures Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
S.454, Strengthening Program Integrity and Accountability in Health Care Act of 2011, a bill to prevent fraud, waste, and abuse under Medicare, Medicaid, and CHIP, and for other purposes H.R. 675, Strengthening Medicare Anti-Fraud Measures Act of 2011, to expand the permissive exclusion from participation in Federal health care programs to individuals and entities affiliated with sanctioned entities
To amend the Internal Revenue Code of 1986 to repeal the medical device tax, and for other purposes.
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
S.17, the Medical Device Access and Innovation Protection Act- a bill to repeal the medical device tax S.262, A bill to repeal the excise tax on medical device manufacturers H.R. 436, the Protect Medical Innovation Act- a bill to repeal the medical device tax H.R. 734, To amend the Internal Revenue Code of 1986 to repeal the medical device tax; H.R. 488, Save Our Medical Devices Act of 2011- a bill to repeal the medical device tax H.R. 942, American Research and Competitiveness Act of 2011- a bill to extend the research credit through 2012 S. 239, the Innovate America Act, a bill to support innovation through tax credits such as research and development Corporate tax reform- specifically the treatment of international earnings
To amend the Internal Revenue Code of 1986 to repeal the medical device tax, and for other purposes.
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
S.17, the Medical Device Access and Innovation Protection Act- a bill to repeal the medical device tax S.262, A bill to repeal the excise tax on medical device manufacturers H.R. 436, the Protect Medical Innovation Act- a bill to repeal the medical device tax H.R. 734, To amend the Internal Revenue Code of 1986 to repeal the medical device tax; H.R. 488, Save Our Medical Devices Act of 2011- a bill to repeal the medical device tax H.R. 942, American Research and Competitiveness Act of 2011- a bill to extend the research credit through 2012 S. 239, the Innovate America Act, a bill to support innovation through tax credits such as research and development
To amend the Internal Revenue Code of 1986 to repeal the medical device tax, and for other purposes.
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
S.17, the Medical Device Access and Innovation Protection Act- a bill to repeal the medical device tax S.262, A bill to repeal the excise tax on medical device manufacturers H.R. 436, the Protect Medical Innovation Act- a bill to repeal the medical device tax H.R. 734, To amend the Internal Revenue Code of 1986 to repeal the medical device tax; H.R. 488, Save Our Medical Devices Act of 2011- a bill to repeal the medical device tax H.R. 942, American Research and Competitiveness Act of 2011- a bill to extend the research credit through 2012 S. 239, the Innovate America Act, a bill to support innovation through tax credits such as research and development S. 1866, the Agree Act which calls for an increase in the rate of the alternative simplified research tax credit and makes such credit permanent Corporate tax reform- specifically the treatment of international earnings including the Chairman's International Tax Reform discussion draft
To amend the Internal Revenue Code of 1986 to repeal the medical device tax, and for other purposes.
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
S.17, the Medical Device Access and Innovation Protection Act- a bill to repeal the medical device tax S.262, A bill to repeal the excise tax on medical device manufacturers H.R. 436, the Protect Medical Innovation Act- a bill to repeal the medical device tax H.R. 734, To amend the Internal Revenue Code of 1986 to repeal the medical device tax; H.R. 488, Save Our Medical Devices Act of 2011- a bill to repeal the medical device tax H.R. 942, American Research and Competitiveness Act of 2011- a bill to extend the research credit through 2012 S. 239, the Innovate America Act, a bill to support innovation through tax credits such as research and development Corporate tax reform- specifically the treatment of international earnings
American Research and Competitiveness Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
S.17, the Medical Device Access and Innovation Protection Act- a bill to repeal the medical device tax S.262, A bill to repeal the excise tax on medical device manufacturers H.R. 436, the Protect Medical Innovation Act- a bill to repeal the medical device tax H.R. 734, To amend the Internal Revenue Code of 1986 to repeal the medical device tax; H.R. 488, Save Our Medical Devices Act of 2011- a bill to repeal the medical device tax H.R. 942, American Research and Competitiveness Act of 2011- a bill to extend the research credit through 2012 S. 239, the Innovate America Act, a bill to support innovation through tax credits such as research and development S. 1866, the Agree Act which calls for an increase in the rate of the alternative simplified research tax credit and makes such credit permanent Corporate tax reform- specifically the treatment of international earnings including the Chairman's International Tax Reform discussion draft
American Research and Competitiveness Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
S.17, the Medical Device Access and Innovation Protection Act- a bill to repeal the medical device tax S.262, A bill to repeal the excise tax on medical device manufacturers H.R. 436, the Protect Medical Innovation Act- a bill to repeal the medical device tax H.R. 734, To amend the Internal Revenue Code of 1986 to repeal the medical device tax; H.R. 488, Save Our Medical Devices Act of 2011- a bill to repeal the medical device tax H.R. 942, American Research and Competitiveness Act of 2011- a bill to extend the research credit through 2012 S. 239, the Innovate America Act, a bill to support innovation through tax credits such as research and development Corporate tax reform- specifically the treatment of international earnings
American Research and Competitiveness Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
S.17, the Medical Device Access and Innovation Protection Act- a bill to repeal the medical device tax S.262, A bill to repeal the excise tax on medical device manufacturers H.R. 436, the Protect Medical Innovation Act- a bill to repeal the medical device tax H.R. 734, To amend the Internal Revenue Code of 1986 to repeal the medical device tax; H.R. 488, Save Our Medical Devices Act of 2011- a bill to repeal the medical device tax H.R. 942, American Research and Competitiveness Act of 2011- a bill to extend the research credit through 2012 S. 239, the Innovate America Act, a bill to support innovation through tax credits such as research and development
American Research and Competitiveness Act of 2011
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
S.17, the Medical Device Access and Innovation Protection Act- a bill to repeal the medical device tax S.262, A bill to repeal the excise tax on medical device manufacturers H.R. 436, the Protect Medical Innovation Act- a bill to repeal the medical device tax H.R. 734, To amend the Internal Revenue Code of 1986 to repeal the medical device tax; H.R. 488, Save Our Medical Devices Act of 2011- a bill to repeal the medical device tax H.R. 942, American Research and Competitiveness Act of 2011- a bill to extend the research credit through 2012 S. 239, the Innovate America Act, a bill to support innovation through tax credits such as research and development Corporate tax reform- specifically the treatment of international earnings
HEART for Women Act
Client: BOSTON SCIENTIFIC CORPORATION · Firm: BOSTON SCIENTIFIC CORPORATION
Implementation of H.R. 3590, the Patient Protection and Affordable Care Act, to provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes. Implementation of H.R. 4872, the Health Care and Reconciliation Act of 2010, a bill that makes a number of health-related financing and revenue changes to the Patient Protection and Affordable Care Act, specifically regarding the medical device tax. S.540, Medical Device Safety Act, a bill that would remove federal preemption protection for certain medical devices H.R.1346, Medical Device Safety Act, a bill that would remove federal preemption protection for certain medical devices Reform of the 510 (k) regulatory pathway H.R. 759, Food and Drug Administration Globalization Act, a bill to improve the safety of food, drugs, devices, and cosmetics S. 882, the Drug and Device Accountability Act, a bill to ensure the safety and quality of medical products and enhance the authorities of the FDA H.R. 2502, Comparative Effectiveness Research Act of 2009, a bill to provide for the conduct of comparative effectiveness research for drugs, devices, and other therapies and create a Comparative Effectiveness Research Trust Fund S.1213, Patient-Centered Outcomes Research Act of 2009, a bill to provide for the conduct of comparative effectiveness research for drugs, devices, and other therapies and to establish a Patient-Centered Outcomes Research Trust Fund H.R. 2824, Doctor-Patient Relationship and Research Protection Act, a bill to support federally funded comparative effectiveness research for drugs, devices, and other therapies S.1142, Informed Health Care Decision Making Act, a bill with respect to the inclusion of effectiveness information in drug and device labeling and advertising H.R. 3090, Health Equity & Accountability Act of 2009, provides for the elimination of racial and ethnic health disparities S.660, National Pain Care Policy Act, a bill to promote greater access to chronic pain therapies H.R. 756, National Pain Care Policy Act, a bill to promote greater access to chronic pain therapies H.R. 4700, the Transparency in All Health Care Pricing Act of 2010, to provide for transparency in health care pricing H.R. 2249, the Health Care Price Transparency Promotion Act of 2009, to provide for increased price transparency of hospital information and to provide for additional research on consumer information on charges and out-of-pocket costs. H.R. 4803, the Patients Right to Know Act, to ensure health care consumer and provider access to certain health benefits plan information and to amend title XIX of the Social Security Act to provide transparency in hospital price and quality information. H.R.1032, Heart Disease Education, Analysis Research, and Treatment for Women Act to amend the Public Health Service Act to improve the prevention, diagnosis, and treatment of heart disease, stroke, and other cardiovascular diseases in women. S.422, Heart Disease Education, Analysis Research, and Treatment for Women Act to amend the Public Health Service Act to improve the prevention, diagnosis, and treatment of heart disease, stroke, and other cardiovascular diseases in women.
Implementation Food and Drug Administration Safety and Innovation Act FDASIA - Public Law 112-144
H.R. 933 - Consolidated and Further Continuing Appropriations Act, 2013 -- Specifically provisions providing appropriations for the FDA's Center for Device and Radiological Health (CDRH) evaulation of medical technology
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
BOSTON SCIENTIFIC CORPORATION via BOSTON SCIENTIFIC CORPORATION
2012 · fourth_quarter · Q4
S.17, the Medical Device and Innovation Protection Act - a bill to repeal the medical device tax S. 262, A bill to repeal the excise tax on medical device manufacturers H.R. 436, the Protect Medical Innovation Act - a bill to repeal the medical device tax H.R. 734, To amend the Internal Revenue Code of 1986 to repeal the medical device tax; H.R.488, Save Our Medical Devices Act of 2011 - a bill to repeal the medical device tax H.R. 942, American Research and Competitiveness Act of 2011 - a bill to extend the research credit through 2012 S.239, the Innovate America Act, a bill to support innovation through tax credits such as research and development S. 1866, the Agree Act which calls for an increase in the rate of hte alternative simplified research tax credit and makes such credit permanent Corporate tax reform - specifically the treatment of international earnings including the Chairman's International Tax Reform
Cybersecurity - Provisions related to setting standards for information sharing between public and private entities regarding Cyber attacks
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination H.R. 5651 - Food and Drug Administration Reform Act 2012 - A bill to renew the FDA User Fee program and to reform the medical device review program. S. 3187 - FDA Safety and Innovation Act - A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes. Senate draft legislation to establish a national track and trace system for pharmaceuticals, specifically relating to convenience kits
S. 758, A bill to establish a Science, Technology, Engineering and Math (STEM) Master Teacher Corps program S. 716, Innovation Inspiration School Grant Program Act - to promote STEM education H.R. 3373 - STEM Education innovation Act - to promote STEM education H.R. 6517 - The STEM Network Act - to promote STEM education
Appropriations for pain management awareness programs H.R. 5973 Agriculture, Rural Development, FDA & Related Agencies Appropriations Act 2013 S. 2375 Agriculture, Rural Development, FDA & Related Agencies Appropriations Act 2013 H.J. Res. 117 - Continuing Appropriations Act - provisions related to user fees for FDA
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
BOSTON SCIENTIFIC CORPORATION via BOSTON SCIENTIFIC CORPORATION
2012 · third_quarter · Q3
S. 758, A bill to establish a Science, Technology, Engineering, and Math (STEM) Master Teacher Corps program S. 716, Innovation Inspiration School Grant Program Act - to promote STEM education H.R. 3373 - STEM Education Innovation Act - to promote STEM education H.R. 6517 - The STEM Network Act - to promote STEM education
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the FDA medical device regulatory system particularly to promote greater efficiency, transparency, and predictability, particularly through the 510(k) system. The following bills accomplish those goals: H.R. 3209 - Premarket Predicability Act H.R. 3203 - Novel Device Regulatory Relief Act H.R. 3230 - Keeping America Competitive through Harmonization Act H.R. 3205 - FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 - Humanitarian Device Reform Act H.R. 3208 - Patients Come First Act H.R. 3206 - Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 - Food and Drug Administration Mission Reform Act H.R. 3207 - Modernizing Laboratory Test Standards for Patients Act H.R. 3204 - Guidance Accountability and Transparency Act H.R. 3847 - Safety of Untested and New Devices Act of 2012 H.R. 3975 - A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 H.R. 4056 - Science and Technology Regulatory Relief Act H.R. 5651 - Food and Drug Administration Reform Act 2012 S. 1700 - The Medical Device Regulatory Improvement Act S. 1865 - The Patient Access to Medical Innovation Act S. 1943 - Novel Device Regulatory Relief Act of 2011 S. 1972 - A bill to amend the Food and Drug Administration's mission S. 1995 - A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. S. 2067 - Safe, Transparent, and Efficient Medical Device Act S. 2113 - A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health S. 2193 - Ensuring Safe Medical Devices for Patients S. 3187 - A bill to amend the Federal Food, Drug, and Cosetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes
S. 17, the Medical Device and Innovation Protection Act - a bill to repeal the medical device tax S. 262, A bill to repeal the excise tax on medical device manufacturers H.R. 436, the Protect Medical Innovation Act - a bill to repeal the medical device tax H.R. 734, To amend the Internal Revenue Code of 1986 to repeal the medical device tax; H.R. 488, Save Our Medical Devices Act of 2011 - a bill to repeal the medical device tax H.R. 942, American Research and Competitiveness Act of 2011 - a bill to extend the research credit through 2012 S. 239, the Innovate America Act, a bill to support innovation through tax credits such as research and development S. 1866, the Agree Act which calls for an increase in the rate of the alternative simplified research tax credit and makes such credit permanent Corporate tax reform - specifically the treatment of international earnings including the Chairman's International Tax Reform discussion draft
Appropriations for the Food and Drug Administration, particularly the Center for Devices and Radiological Health Appropriations for pain management awareness programs H.R. 5973 Agriculture, Rural Development, FDA & Related Agencies Appropriations Act 2013 S. 2375 Agriculture, Rural Development, FDA & Related Agencies Appropriations Act 2013 H.J. Res. 117 - Continuing Appropriations Act - provisions related to user fees for FDA
Cybersecurity - Provisions related to setting standards for information sharing between public and private entities regarding Cyber attacks
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BOSTON SCIENTIFIC CORPORATION via BOSTON SCIENTIFIC CORPORATION
2012 · second_quarter · Q2
Appropriations for the Food and Drug Administration, particularly the Center for Devices and Radiological Health Appropriations for pain management awareness programs HR5973 Agriculture, Rural Development, FDA & Related Agencies Appropriations Act 2013 S. 2375 Agriculture, Rural Development, FDA & Related Agencies Appropriations Act 2013
S.758, A bill to establish a Science, Technology, Engineering, and Math (STEM) Master Teacher Corps program S.716, Innovation Inspiration School Grant Program Act- to promote STEM education H.R. 3373- STEM Education Innovation Act- to promote STEM education
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the medical device regulatory system particularly for Class II devices through the 510(k) system including the following FDA related legislation: H.R. 3209 -Premarket Predictability Act H.R. 3203 -Novel Device Regulatory Relief Act H.R. 3230 -Keeping America Competitive through Harmonization Act H.R. 3205 -FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 -Humanitarian Device Reform Act H.R. 3208 -Patients Come First Act H.R. 3206 -Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 -Food and Drug Administration Mission Reform Act H.R. 3207 -Modernizing Laboratory Test Standards for Patients Act H.R. 3204 -Guidance Accountability and Transparency Act H.R. 3847- Safety of Untested and New Devices Act of 2012 H.R. 3975- A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 H.R. 4056- Science and Technology Regulatory Relief Act H.R. 5651- Food and Drug Administration Reform Act of 2012 S. 1700 -The Medical Device Regulatory Improvement Act S. 1865 -The Patient Access to Medical Innovation Act S. 1943 -Novel Device Regulatory Relief Act of 2011 S. 1972 -A bill to amend the Food and Drug Administration's mission S. 1995 -A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. S. 2067- Safe, Transparent, and Efficient Medical Device Act S.2113- A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health S. 2193- Ensuring Safe Medical Devices for Patients S.3187- A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes
S.17, the Medical Device Access and Innovation Protection Act- a bill to repeal the medical device tax S.262, A bill to repeal the excise tax on medical device manufacturers H.R. 436, the Protect Medical Innovation Act- a bill to repeal the medical device tax H.R. 734, To amend the Internal Revenue Code of 1986 to repeal the medical device tax; H.R. 488, Save Our Medical Devices Act of 2011- a bill to repeal the medical device tax H.R. 942, American Research and Competitiveness Act of 2011- a bill to extend the research credit through 2012 S. 239, the Innovate America Act, a bill to support innovation through tax credits such as research and development S. 1866, the Agree Act which calls for an increase in the rate of the alternative simplified research tax credit and makes such credit permanent Corporate tax reform- specifically the treatment of international earnings including the Chairman's International Tax Reform discussion draft
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
BOSTON SCIENTIFIC CORPORATION via BOSTON SCIENTIFIC CORPORATION
2012 · first_quarter · Q1
Appropriations for the Food and Drug Administration, particularly the Center for Devices and Radiological Health Appropriations for pain management awareness programs
S.758, A bill to establish a Science, Technology, Engineering, and Math (STEM) Master Teacher Corps program S.716, Innovation Inspiration School Grant Program Act- to promote STEM education
S.17, the Medical Device Access and Innovation Protection Act- a bill to repeal the medical device tax S.262, A bill to repeal the excise tax on medical device manufacturers H.R. 436, the Protect Medical Innovation Act- a bill to repeal the medical device tax H.R. 734, To amend the Internal Revenue Code of 1986 to repeal the medical device tax; H.R. 488, Save Our Medical Devices Act of 2011- a bill to repeal the medical device tax H.R. 942, American Research and Competitiveness Act of 2011- a bill to extend the research credit through 2012 S. 239, the Innovate America Act, a bill to support innovation through tax credits such as research and development S. 1866, the Agree Act which calls for an increase in the rate of the alternative simplified research tax credit and makes such credit permanent Corporate tax reform- specifically the treatment of international earnings including the Chairman's International Tax Reform discussion draft
H.R. 658, the FAA Reauthorization and Reform Act of 2011, provisions related to the transportation of lithium batteries S.223, the FAA Reauthorization and Reform Act of 2011, provisions related to the transportation of lithium batteries
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the medical device regulatory system particularly for Class II devices through the 510(k) system including the following FDA related legislation: H.R. 3209 -Premarket Predictability Act H.R. 3203 -Novel Device Regulatory Relief Act H.R. 3230 -Keeping America Competitive through Harmonization Act H.R. 3205 -FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 -Humanitarian Device Reform Act H.R. 3208 -Patients Come First Act H.R. 3206 -Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 -Food and Drug Administration Mission Reform Act H.R. 3207 -Modernizing Laboratory Test Standards for Patients Act H.R. 3204 -Guidance Accountability and Transparency Act H.R. 3847- Safety of Untested and New Devices Act of 2012 H.R. 3975- A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 H.R. 4056- Science and Technology Regulatory Relief Act S. 1700 -The Medical Device Regulatory Improvement Act S. 1865 -The Patient Access to Medical Innovation Act S. 1943 -Novel Device Regulatory Relief Act of 2011 S. 1972 -A bill to amend the Food and Drug Administration's mission S. 1995 -A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. S. 2067- Safe, Transparent, and Efficient Medical Device Act S.2113- A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health S. 2193- Ensuring Safe Medical Devices for Patients Discussion drafts on user fee legislation from the Energy and Commerce Committee and the Health, Education, Labor and Pensions Committee
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
BOSTON SCIENTIFIC CORPORATION via BOSTON SCIENTIFIC CORPORATION
2011 · fourth_quarter · Q4
Proposed rules regarding disclosure related to conflict minerals
S.454, Strengthening Program Integrity and Accountability in Health Care Act of 2011, a bill to prevent fraud, waste, and abuse under Medicare, Medicaid, and CHIP, and for other purposes H.R. 675, Strengthening Medicare Anti-Fraud Measures Act of 2011, to expand the permissive exclusion from participation in Federal health care programs to individuals and entities affiliated with sanctioned entities
S.17, the Medical Device Access and Innovation Protection Act- a bill to repeal the medical device tax S.262, A bill to repeal the excise tax on medical device manufacturers H.R. 436, the Protect Medical Innovation Act- a bill to repeal the medical device tax H.R. 734, To amend the Internal Revenue Code of 1986 to repeal the medical device tax; H.R. 488, Save Our Medical Devices Act of 2011- a bill to repeal the medical device tax H.R. 942, American Research and Competitiveness Act of 2011- a bill to extend the research credit through 2012 S. 239, the Innovate America Act, a bill to support innovation through tax credits such as research and development S. 1866, the Agree Act which calls for an increase in the rate of the alternative simplified research tax credit and makes such credit permanent Corporate tax reform- specifically the treatment of international earnings including the Chairman's International Tax Reform discussion draft
BOSTON SCIENTIFIC CORPORATION via BOSTON SCIENTIFIC CORPORATION
2011 · third_quarter · Q3
S.758, A bill to establish a Science, Technology, Engineering, and Math (STEM) Master Teacher Corps program S.716, Innovation Inspiration School Grant Program Act- to promote STEM education
Proposed rules regarding disclosure related to conflict minerals
H.R. 658, the FAA Reauthorization and Reform Act of 2011, provisions related to the transportation of lithium batteries S.223, the FAA Reauthorization and Reform Act of 2011, provisions related to the transportation of lithium batteries
BOSTON SCIENTIFIC CORPORATION via BOSTON SCIENTIFIC CORPORATION
2011 · second_quarter · Q2
S.758, A bill to establish a Science, Technology, Engineering, and Math (STEM) Master Teacher Corps program S.716, Innovation Inspiration School Grant Program Act- to promote STEM education
Reform of the medical device regulatory system particularly for Class II devices through the 510(k) system Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research
H.R. 658, the FAA Reauthorization and Reform Act of 2011, provisions related to the transportation of lithium batteries S.223, the FAA Reauthorization and Reform Act of 2011, provisions related to the transportation of lithium batteries
BOSTON SCIENTIFIC CORPORATION via BOSTON SCIENTIFIC CORPORATION
2011 · first_quarter · Q1
S.758, A bill to establish a Science, Technology, Engineering, and Math (STEM) Master Teacher Corps program S.716, Innovation Inspiration School Grant Program Act- to promote STEM education
S.17, the Medical Device Access and Innovation Protection Act- a bill to repeal the medical device tax S.262, A bill to repeal the excise tax on medical device manufacturers H.R. 436, the Protect Medical Innovation Act- a bill to repeal the medical device tax H.R. 734, To amend the Internal Revenue Code of 1986 to repeal the medical device tax; H.R. 488, Save Our Medical Devices Act of 2011- a bill to repeal the medical device tax H.R. 942, American Research and Competitiveness Act of 2011- a bill to extend the research credit through 2012 S. 239, the Innovate America Act, a bill to support innovation through tax credits such as research and development
BOSTON SCIENTIFIC CORPORATION via BOSTON SCIENTIFIC CORPORATION
2010 · fourth_quarter · Q4
Implementation of H.R. 3590, the Patient Protection and Affordable Care Act, to provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes. Implementation of H.R. 4872, the Health Care and Reconciliation Act of 2010, a bill that makes a number of health-related financing and revenue changes to the Patient Protection and Affordable Care Act, specifically regarding the medical device tax. S.540, Medical Device Safety Act, a bill that would remove federal preemption protection for certain medical devices H.R.1346, Medical Device Safety Act, a bill that would remove federal preemption protection for certain medical devices Reform of the 510 (k) regulatory pathway H.R. 759, Food and Drug Administration Globalization Act, a bill to improve the safety of food, drugs, devices, and cosmetics S. 882, the Drug and Device Accountability Act, a bill to ensure the safety and quality of medical products and enhance the authorities of the FDA H.R. 2502, Comparative Effectiveness Research Act of 2009, a bill to provide for the conduct of comparative effectiveness research for drugs, devices, and other therapies and create a Comparative Effectiveness Research Trust Fund S.1213, Patient-Centered Outcomes Research Act of 2009, a bill to provide for the conduct of comparative effectiveness research for drugs, devices, and other therapies and to establish a Patient-Centered Outcomes Research Trust Fund H.R. 2824, Doctor-Patient Relationship and Research Protection Act, a bill to support federally funded comparative effectiveness research for drugs, devices, and other therapies S.1142, Informed Health Care Decision Making Act, a bill with respect to the inclusion of effectiveness information in drug and device labeling and advertising H.R. 3090, Health Equity & Accountability Act of 2009, provides for the elimination of racial and ethnic health disparities S.660, National Pain Care Policy Act, a bill to promote greater access to chronic pain therapies H.R. 756, National Pain Care Policy Act, a bill to promote greater access to chronic pain therapies H.R. 4700, the Transparency in All Health Care Pricing Act of 2010, to provide for transparency in health care pricing H.R. 2249, the Health Care Price Transparency Promotion Act of 2009, to provide for increased price transparency of hospital information and to provide for additional research on consumer information on charges and out-of-pocket costs. H.R. 4803, the Patients Right to Know Act, to ensure health care consumer and provider access to certain health benefits plan information and to amend title XIX of the Social Security Act to provide transparency in hospital price and quality information. H.R.1032, Heart Disease Education, Analysis Research, and Treatment for Women Act to amend the Public Health Service Act to improve the prevention, diagnosis, and treatment of heart disease, stroke, and other cardiovascular diseases in women. S.422, Heart Disease Education, Analysis Research, and Treatment for Women Act to amend the Public Health Service Act to improve the prevention, diagnosis, and treatment of heart disease, stroke, and other cardiovascular diseases in women.
BOSTON SCIENTIFIC CORPORATION via BOSTON SCIENTIFIC CORPORATION
2010 · third_quarter · Q3
HR 2749, Food Safety Enhancement Act of 2009, grants FDA the authority and resources to oversee the safety of the nation's food supply. Includes provisions related to registration fees, device import safety fees, and unique identifier provisions.
H.R. 4016, the Hazardous Materials Transportation Safety Act of 2009, specifically regarding the transportation of lithium batteries
The FY2011 budget proposal and provisions related to the taxation of foreign earnings of U.S. multinational corporations. S. 3816, Creating American Jobs and Ending Offshoring Act, a bill that would limit deferral for U.S. companies that move production overseas and then import products back to the United States. S.1203, the GROWTH Act, a bill to extend the research credit through 2010 and to increase and make permanent the alternative simplified research credit HR 4213, American Jobs and Closing Tax Loopholes Act, a bill that includes extension of the R&D tax credit
BOSTON SCIENTIFIC CORPORATION via BOSTON SCIENTIFIC CORPORATION
2010 · second_quarter · Q2
S.660, National Pain Care Policy Act, a bill to promote greater access to chronic pain therapies H.R. 756, National Pain Care Policy Act, a bill to promote greater access to chronic pain therapies S.1380, Medicare Payment Advisory Commission (MedPAC) Reform Act, a bill to make the commission an executive branch agency, and provide the Commission new resources and authority to implement Medicare payment policy S.301, Physician Payments Sunshine Act, a bill that would require disclosure of the relationships between physicians and the manufacturers of drugs and devices H.R. 3138, Physician Payments Sunshine Act, a bill that would require disclosure of the relationships between physicians and the manufacturers of drugs and devices H.R. 2502, Comparative Effectiveness Research Act of 2009, a bill to provide for the conduct of comparative effectiveness research for drugs, devices, and other therapies and create a Comparative Effectiveness Research Trust Fund S.1213, Patient-Centered Outcomes Research Act of 2009, a bill to provide for the conduct of comparative effectiveness research for drugs, devices, and other therapies and to establish a Patient-Centered Outcomes Research Trust Fund H.R. 2824, Doctor-Patient Relationship and Research Protection Act, a bill to support federally funded comparative effectiveness research for drugs, devices, and other therapies S.1142, Informed Health Care Decision Making Act, a bill with respect to the inclusion of effectiveness information in drug and device labeling and advertising H.R. 4700, the Transparency in All Health Care Pricing Act of 2010, to provide for transparency in health care pricing H.R. 2249, the Health Care Price Transparency Promotion Act of 2009, to provide for increased price transparency of hospital information and to provide for additional research on consumer information on charges and out-of-pocket costs. H.R. 4803, the Patients Right to Know Act, to ensure health care consumer and provider access to certain health benefits plan information and to amend title XIX of the Social Security Act to provide transparency in hospital price and quality information
BOSTON SCIENTIFIC CORPORATION via BOSTON SCIENTIFIC CORPORATION
2010 · first_quarter · Q1
Medical device tax as included as a means to pay for health care reform in H.R. 3590, the Patient Protection and Affordable Care Act and H.R. 4872, the Health Care and Education Reconciliation Act of 2010. The FY2011 budget proposal and provisions related to the taxation of foreign earnings of U.S. multinational corporations S.1203, the GROWTH Act, a bill to extend the research credit through 2010 and to increase and make permanent the alternative simplified research credit HR 4213, a bill that includes extension of the R&D tax credit
H.R. 3590, the Patient Protection and Affordable Care Act, to provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes. H.R. 4872, the Health Care and Reconciliation Act of 2010, a bill that makes a number of health-related financing and revenue changes to the Patient Protection and Affordable Care Act, specifically regarding the medical device tax. Provisions within the health care reform bills with an emphasis on physician disclosure, comparative effectiveness research, pain research, Medicare secondary payer, bundling, gainsharing, medical device registry, and medical device tax. S.540, Medical Device Safety Act, a bill that would remove federal preemption protection for certain medical devices H.R.1346, Medical Device Safety Act, a bill that would remove federal preemption protection for certain medical devices Reform of the 510 (k) regulatory pathway H.R. 759, Food and Drug Administration Globalization Act, a bill to improve the safety of food, drugs, devices, and cosmetics S. 882, the Drug and Device Accountability Act, a bill to ensure the safety and quality of medical products and enhance the authorities of the FDA H.R. 2502, Comparative Effectiveness Research Act of 2009, a bill to provide for the conduct of comparative effectiveness research for drugs, devices, and other therapies and create a Comparative Effectiveness Research Trust Fund S.1213, Patient-Centered Outcomes Research Act of 2009, a bill to provide for the conduct of comparative effectiveness research for drugs, devices, and other therapies and to establish a Patient-Centered Outcomes Research Trust Fund H.R. 2824, Doctor-Patient Relationship and Research Protection Act, a bill to support federally funded comparative effectiveness research for drugs, devices, and other therapies S.1142, Informed Health Care Decision Making Act, a bill with respect to the inclusion of effectiveness information in drug and device labeling and advertising H.R. 3090, Health Equity & Accountability Act of 2009, provides for the elimination of racial and ethnic health disparities S.660, National Pain Care Policy Act, a bill to promote greater access to chronic pain therapies H.R. 756, National Pain Care Policy Act, a bill to promote greater access to chronic pain therapies
BOSTON SCIENTIFIC CORPORATION via BOSTON SCIENTIFIC CORPORATION
2009 · fourth_quarter · Q4
S.560, the Employee Free Choice Act, a bill to establish an efficient system to enable employees to form, join, or assist labor organizations and to provide for mandatory injunctions for unfair labor practices during the organizing efforts H.R. 1409, the Employee Free Choice Act, a bill to establish an efficient system to enable employees to form, join, assist labor organizations, and to provide for mandatory injunctions for unfair labor practices during the organizing efforts
S.660, National Pain Care Policy Act, a bill to promote greater access to chronic pain therapies H.R. 756, National Pain Care Policy Act, a bill to promote greater access to chronic pain therapies S.1380, Medicare Payment Advisory Commission (MedPAC) Reform Act, a bill to make the commission an executive branch agency, and provide the Commission new resources and authority to implement Medicare payment policy S.301, Physician Payments Sunshine Act, a bill that would require disclosure of the relationships between physicians and the manufacturers of drugs and devices H.R. 3138, Physician Payments Sunshine Act, a bill that would require disclosure of the relationships between physicians and the manufacturers of drugs and devices H.R. 2502, Comparative Effectiveness Research Act of 2009, a bill to provide for the conduct of comparative effectiveness research for drugs, devices, and other therapies and create a Comparative Effectiveness Research Trust Fund S.1213, Patient-Centered Outcomes Research Act of 2009, a bill to provide for the conduct of comparative effectiveness research for drugs, devices, and other therapies and to establish a Patient-Centered Outcomes Research Trust Fund H.R. 2824, Doctor-Patient Relationship and Research Protection Act, a bill to support federally funded comparative effectiveness research for drugs, devices, and other therapies S.1142, Informed Health Care Decision Making Act, a bill with respect to the inclusion of effectiveness information in drug and device labeling and advertising
BOSTON SCIENTIFIC CORPORATION via BOSTON SCIENTIFIC CORPORATION
2009 · third_quarter · Q3
HR. 2454, American Clean Energy and Security Act, a bill to create clean energy jobs, achieve energy independence, reduce global warming pollution and transition to a clean energy economy S.5 a bill to reduce the dependence on foreign and unsustainable energy sources and risks of global warming
Market Access, regulatory approvals and reimbursement for medical devices in Japan, EU, Korea, China, Brazil Trade agreements with Columbia and South Korea
S.660, National Pain Care Policy Act, a bill to promote greater access to chronic pain therapies H.R. 756, National Pain Care Policy Act, a bill to promote greater access to chronic pain therapies S.1380, Medicare Payment Advisory Commission (MedPAC) Reform Act, a bill to make the commission an executive branch agency, and provide the Commission new resources and authority to implement Medicare payment policy S.301, Physician Payments Sunshine Act, a bill that would require disclosure of the relationships between physicians and the manufacturers of drugs and devices H.R. 3138, Physician Payments Sunshine Act, a bill that would require disclosure of the relationships between physicians and the manufacturers of drugs and devices H.R. 2502, Comparative Effectiveness Research Act of 2009, a bill to provide for the conduct of comparative effectiveness research for drugs, devices, and other therapies and create a Comparative Effectiveness Research Trust Fund S.1213, Patient-Centered Outcomes Research Act of 2009, a bill to provide for the conduct of comparative effectiveness research for drugs, devices, and other therapies and to establish a Patient-Centered Outcomes Research Trust Fund H.R. 2824, Doctor-Patient Relationship and Research Protection Act, a bill to support federally funded comparative effectiveness research for drugs, devices, and other therapies S.1142, Informed Health Care Decision Making Act, a bill with respect to the inclusion of effectiveness information in drug and device labeling and advertising Medicare Secondary Payer provision, which was included in Ways and Means Chairman's Mark for HR 3200, the America's Affordable Health Choices Act, that would have increased exposure to liability for suppliers, including device manufacturers
BOSTON SCIENTIFIC CORPORATION via BOSTON SCIENTIFIC CORPORATION
2009 · second_quarter · Q2
Market Access, regulatory approvals and reimbursement for medical devices in Japan, EU, Korea, China, Brazil Trade agreements with Columbia and South Korea
H.R. 422, a bill to permanently extend and strengthen the federal R & D tax credit S.1203, the GROWTH Act, a bill to extend the research credit through 2010 and to increase and make permanent the alternative simplified research credit Deferral tax as mentioned in the President's proposed budget for 2010 and as a proposed payment for health reform
S.515. Patent Reform Act of 2009, provisions related specifically to innovative technologies H.R. 1260, Patent Reform Act of 2009, provisions related specifically to innovative technologies
BOSTON SCIENTIFIC CORPORATION via BOSTON SCIENTIFIC CORPORATION
2009 · first_quarter · Q1
HR1 American Recovery and Reinvestment Act of 2009, a bill that provides funding for comparative effectiveness research HR 576 National Pain Care Policy Act, a bill to promote greater access to chronic pain therapies S 660 National Pain Care Policy Act, a bill to promote greater access to chronic pain therapies S 301 Physician Payments Sunshine Act, a bill that would require disclosure of the relationships between physicians and the manufacturers of drugs and devices Medicare Coverage of BSC Clinical Study Comparative Effectiveness as related to the yet to be introduced Baucus/Conrad bill (S.3408 from 110th Congress)
S 560 the Employee Free Choice Act of 2009, a bill concerning labor unions HR 1409 the Employee Free Choice Act of 2009, a bill concerning labor unions
BOSTON SCIENTIFIC CORPORATION via BOSTON SCIENTIFIC CORPORATION
2008 · fourth_quarter · Q4
- HR 2138 Investment in America Act of 2007, a bill to permanently extend and strentghen the R&D tax credit. - S. 2209 Investment in America Act of 2007, a bill to permanently extend and strentghen the R&D tax credit. - HR 1424 Emergency Economic Stabilization Act of 2008, a bill to permanently extend and strentghen the R&D tax credit. - HR 6049 Energy Improvement and Extension Act of 2008, a bill to permanently extend and strentghen the R&D tax credit.
- Market Access, regulatory approvals and reimbursement for medical devices in Japan, EU, Korea, China, Brazil. - Trade Agreements with Columbia, South Korea.
BOSTON SCIENTIFIC CORPORATION via BOSTON SCIENTIFIC CORPORATION
2008 · third_quarter · Q3
- Food and Drug Administration Globalization Act of 2008, a bill to increase FDA inspection of manufacturers in the US and abroad. - HR 6381Medical Device Safety Act of 2008, a bill that would remove federal preemption protection for certain medical devices. - HR 2900 Implementation of Food and Drug Administration Amendments Act of 2007, a bill to revise and extend the user-fee programs for prescription drugs and for medical devices. - HR 3014 Health Disparities, a bill to address disparities in the delivery of health care, specifically as it relates to cardiovascular care. - S. 3398 Medical Device Safety Act of 2008, a bill that would remove federal preemption protection for certain medical devices. - HR 6432 Animal Drug User Fee Act, a provision to make technical corrections to device user fee program.
- HR 2138 Investment in America Act of 2007, a bill to permanently extend and strentghen the R&D tax credit. - S. 2209 Investment in America Act of 2007, a bill to permanently extend and strentghen the R&D tax credit. - HR 1424 Emergency Economic Stabilization Act of 2008, a bill to permanently extend and strentghen the R&D tax credit. - HR 6049 Energy Improvement and Extension Act of 2008, a bill to permanently extend and strentghen the R&D tax credit.
BOSTON SCIENTIFIC CORPORATION via BOSTON SCIENTIFIC CORPORATION
2008 · first_quarter · 1A
- HR 2900 Implementation of Food and Drug Administration Amendments Act of 2007 - Medical Device Safety Act 2008 - HR 2419 Farm Bill
- Market Access, regulatory approvals and reimbursement for medical devices in Japan, EU, Korea, China, Brazil - Trade Agreements with Columbia, South Korea
- HR 2138 Investment in America Act of 2007 - S. 2209 Investment in America Act of 2007
BOSTON SCIENTIFIC CORPORATION via BOSTON SCIENTIFIC CORPORATION
2008 · second_quarter · Q2
- HR 2138 Investment in America Act of 2007, a bill to permanently extend and strentghen the R&D tax credit. - S. 2209 Investment in America Act of 2007, a bill to permanently extend and strentghen the R&D tax credit.
- S. 2160 Veterans Pain Care Act, a bill to promote greater access to chronic pain therapies in the VA medical system. - HR 6122 Veterans Pain Care Act, a bill to promote greater access to chronic pain therapies in the VA medical system.
- Market Access, regulatory approvals and reimbursement for medical devices in Japan, EU, Korea, China, Brazil - Trade Agreements with Columbia, South Korea
BOSTON SCIENTIFIC CORPORATION via BOSTON SCIENTIFIC CORPORATION
2008 · first_quarter · Q1
- HR 2138 Investment in America Act of 2007 - S. 2209 Investment in America Act of 2007
- Market Access, regulatory approvals and reimbursement for medical devices in Japan, EU, Korea, China, Brazil - Trade Agreements with Columbia, South Korea
- HR 5465 Military Pain Care Act
BOSTON SCIENTIFIC CORPORATION via BOSTON SCIENTIFIC CORPORATION
2007 · year_end · YA
- Use of dedicated spectrum for medical devices
- S. 1145 Patent Reform Act of 2007 - HR 1908 Patent Reform Act of 2007
- S. 1041 Employee Free Choice Act of 2007 - HR 800 Employee Free Choice Act of 2007
BOSTON SCIENTIFIC CORPORATION via BOSTON SCIENTIFIC CORPORATION
2007 · year_end · YY
- Market Access, regulatory approvals and reimbursement for medical devices in Japan, EU, Korea, China, Brazil - Trade Agreements with Peru, Panama, Colombia, South Korea - HR 3668 United States-Peru Trade Promotion Agreement Implementation Act
- HR 2138 Investment in America Act of 2007 - S. 2209 Investment in America Act of 2007
- S. 1041 Employee Free Choice Act of 2007 - HR 800 Employee Free Choice Act of 2007
BOSTON SCIENTIFIC CORPORATION via BOSTON SCIENTIFIC CORPORATION
2006 · year_end · YA
Filing targets: Centers For Medicare and Medicaid Services (CMS), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, Treasury, Dept of, Veterans Affairs, Dept of (VA)
United States-Korea Free Trade Agreement, provisions specifically related to medical devices Columbia and Panama Free Trade Agreements
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the medical device regulatory system particularly for Class II devices through the 510(k) system including the following FDA related legislation: H.R. 3209 -Premarket Predictability Act H.R. 3203 -Novel Device Regulatory Relief Act H.R. 3230 -Keeping America Competitive through Harmonization Act H.R. 3205 -FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 -Humanitarian Device Reform Act H.R. 3208 -Patients Come First Act H.R. 3206 -Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 -Food and Drug Administration Mission Reform Act H.R. 3207 -Modernizing Laboratory Test Standards for Patients Act H.R. 3204 -Guidance Accountability and Transparency Act S. 1700 -The Medical Device Regulatory Improvement Act S. 1865 -The Patient Access to Medical Innovation Act S. 1943 -Novel Device Regulatory Relief Act of 2011 S. 1972 -A bill to amend the Food and Drug Administration's mission S. 1995 -A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes.
H.R. 658, the FAA Reauthorization and Reform Act of 2011, provisions related to the transportation of lithium batteries S.223, the FAA Reauthorization and Reform Act of 2011, provisions related to the transportation of lithium batteries
Appropriations for the Food and Drug Administration, particularly the Center for Devices and Radiological Health Appropriations for pain management awareness programs
S.758, A bill to establish a Science, Technology, Engineering, and Math (STEM) Master Teacher Corps program S.716, Innovation Inspiration School Grant Program Act- to promote STEM education
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Pipeline & Hazardous Materials Safety Administration, SENATE, Securities & Exchange Commission (SEC), Transportation, Dept of (DOT)
S.23, America Invents Act, provisions related specifically to patents and innovative technologies H.R. 1249, America Invents Act, provisions related specifically to patents and innovative technologies
United States-Korea Free Trade Agreement, provisions specifically related to medical devices Columbia and Panama Free Trade Agreements
Reform of the medical device regulatory system particularly for Class II devices through the 510(k) system Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research
S.17, the Medical Device Access and Innovation Protection Act- a bill to repeal the medical device tax S.262, A bill to repeal the excise tax on medical device manufacturers H.R. 436, the Protect Medical Innovation Act- a bill to repeal the medical device tax H.R. 734, To amend the Internal Revenue Code of 1986 to repeal the medical device tax; H.R. 488, Save Our Medical Devices Act of 2011- a bill to repeal the medical device tax H.R. 942, American Research and Competitiveness Act of 2011- a bill to extend the research credit through 2012 S. 239, the Innovate America Act, a bill to support innovation through tax credits such as research and development Corporate tax reform- specifically the treatment of international earnings
Appropriations for the Food and Drug Administration Appropriations for pain management awareness programs
S.454, Strengthening Program Integrity and Accountability in Health Care Act of 2011, a bill to prevent fraud, waste, and abuse under Medicare, Medicaid, and CHIP, and for other purposes H.R. 675, Strengthening Medicare Anti-Fraud Measures Act of 2011, to expand the permissive exclusion from participation in Federal health care programs to individuals and entities affiliated with sanctioned entities
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), Pipeline & Hazardous Materials Safety Administration, SENATE, Transportation, Dept of (DOT)
United States-Korea Free Trade Agreement, provisions specifically related to medical devices Columbia and Panama Free Trade Agreements
Proposed rules regarding disclosure related to conflict minerals
S.454, Strengthening Program Integrity and Accountability in Health Care Act of 2011, a bill to prevent fraud, waste, and abuse under Medicare, Medicaid, and CHIP, and for other purposes H.R. 675, Strengthening Medicare Anti-Fraud Measures Act of 2011, to expand the permissive exclusion from participation in Federal health care programs to individuals and entities affiliated with sanctioned entities
Appropriations for the Food and Drug Administration Appropriations for pain management awareness programs
S.23, America Invents Act, provisions related specifically to patents and innovative technologies H.R. 1249, America Invents Act, provisions related specifically to patents and innovative technologies
S.17, the Medical Device Access and Innovation Protection Act- a bill to repeal the medical device tax S.262, A bill to repeal the excise tax on medical device manufacturers H.R. 436, the Protect Medical Innovation Act- a bill to repeal the medical device tax H.R. 734, To amend the Internal Revenue Code of 1986 to repeal the medical device tax; H.R. 488, Save Our Medical Devices Act of 2011- a bill to repeal the medical device tax H.R. 942, American Research and Competitiveness Act of 2011- a bill to extend the research credit through 2012 S. 239, the Innovate America Act, a bill to support innovation through tax credits such as research and development Corporate tax reform- specifically the treatment of international earnings
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), Pipeline & Hazardous Materials Safety Administration, SENATE, Transportation, Dept of (DOT)
S.330, Consumer Recall Protection Act of 2011, a bill to prohibit the sale of any product to a consumer that is subject to a recall, and for other purposes.
S.454, Strengthening Program Integrity and Accountability in Health Care Act of 2011, a bill to prevent fraud, waste, and abuse under Medicare, Medicaid, and CHIP, and for other purposes H.R. 675, Strengthening Medicare Anti-Fraud Measures Act of 2011, to expand the permissive exclusion from participation in Federal health care programs to individuals and entities affiliated with sanctioned entities
Proposed rules regarding disclosure related to conflict minerals
Reform of the medical device regulatory system particularly for Class II devices through the 510(k) system
United States-Korea Free Trade Agreement, provisions specifically related to medical devices
S.23, America Invents Act, provisions related specifically to patents and innovative technologies H.R. 1249, America Invents Act, provisions related specifically to patents and innovative technologies
Appropriations for the Food and Drug Administration Appropriations for pain management awareness
H.R. 658, the FAA Reauthorization and Reform Act of 2011, provisions related to the transportation of lithium batteries S.223, the FAA Reauthorization and Reform Act of 2011, provisions related to the transportation of lithium batteries
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), Pipeline & Hazardous Materials Safety Administration, SENATE, Securities & Exchange Commission (SEC), Transportation, Dept of (DOT)
H.R. 4016, the Hazardous Materials Transportation Safety Act of 2009, specifically regarding the transportation of lithium batteries
S.515. Patent Reform Act of 2009, provisions related specifically to innovative technologies H.R. 1260, Patent Reform Act of 2009, provisions related specifically to innovative technologies H.R.5322, Patent and Trademark Office Funding Stabilization Act of 2010, provisions related specifically to innovative technologies H.R. 4954, to provide recourse under the patent law for persons who suffer competitive injury as a result of false markings
The FY2011 budget proposal and provisions related to the taxation of foreign earnings of U.S. multinational corporations. S. 3816, Creating American Jobs and Ending Offshoring Act, a bill that would limit deferral for U.S. companies that move production overseas and then import products back to the United States. S.1203, the GROWTH Act, a bill to extend the research credit through 2010 and to increase and make permanent the alternative simplified research credit H.R.4853, Tax Relief, Unemployment Insurance Reauthorization, and Job Creation Act of 2010, a bill that includes extension of the R&D tax credit
S.660, National Pain Care Policy Act, a bill to promote greater access to chronic pain therapies H.R. 756, National Pain Care Policy Act, a bill to promote greater access to chronic pain therapies S.1380, Medicare Payment Advisory Commission (MedPAC) Reform Act, a bill to make the commission an executive branch agency, and provide the Commission new resources and authority to implement Medicare payment policy S.301, Physician Payments Sunshine Act, a bill that would require disclosure of the relationships between physicians and the manufacturers of drugs and devices H.R. 3138, Physician Payments Sunshine Act, a bill that would require disclosure of the relationships between physicians and the manufacturers of drugs and devices H.R. 2502, Comparative Effectiveness Research Act of 2009, a bill to provide for the conduct of comparative effectiveness research for drugs, devices, and other therapies and create a Comparative Effectiveness Research Trust Fund S.1213, Patient-Centered Outcomes Research Act of 2009, a bill to provide for the conduct of comparative effectiveness research for drugs, devices, and other therapies and to establish a Patient-Centered Outcomes Research Trust Fund H.R. 2824, Doctor-Patient Relationship and Research Protection Act, a bill to support federally funded comparative effectiveness research for drugs, devices, and other therapies S.1142, Informed Health Care Decision Making Act, a bill with respect to the inclusion of effectiveness information in drug and device labeling and advertising H.R. 4700, the Transparency in All Health Care Pricing Act of 2010, to provide for transparency in health care pricing H.R. 2249, the Health Care Price Transparency Promotion Act of 2009, to provide for increased price transparency of hospital information and to provide for additional research on consumer information on charges and out-of-pocket costs. H.R. 4803, the Patients Right to Know Act, to ensure health care consumer and provider access to certain health benefits plan information and to amend title XIX of the Social Security Act to provide transparency in hospital price and quality information
HR 2749, Food Safety Enhancement Act of 2009, grants FDA the authority and resources to oversee the safety of the nation's food supply. Includes provisions related to registration fees, device import safety fees, and unique identifier provisions.
H.R. 3795, to enact the Over-the-Counter Derivatives Markets Act of 2009, provisions related to changing the regulation on over-the-counter derivatives and how they are used by corporations H.R.4173, to provide for financial regulatory reform, to protect consumers and investors, to enhance Federal understanding of insurance issues, to regulate over-the-counter derivatives markets, and for other purposes with provisions specifically changing the regulation on over-the-counter derivatives and how they are used by corporations. S.3217, The Restoring American Financial Stability Act, on financial reform with provisions on the regulation of over-the-counter derivatives and Congo conflict minerals Conference Report H. Rept 111-517,Wall Street Reform and Consumer Protection Act, with provisions on the regulation of over-the-counter derivatives
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE, Transportation, Dept of (DOT)
H.R. 3795, to enact the Over-the-Counter Derivatives Markets Act of 2009, provisions related to changing the regulation on over-the-counter derivatives and how they are used by corporations H.R.4173, to provide for financial regulatory reform, to protect consumers and investors, to enhance Federal understanding of insurance issues, to regulate over-the-counter derivatives markets, and for other purposes with provisions specifically changing the regulation on over-the-counter derivatives and how they are used by corporations. S.3217, The Restoring American Financial Stability Act, on financial reform with provisions on the regulation of over-the-counter derivatives and Congo conflict minerals Conference Report H. Rept 111-517,Wall Street Reform and Consumer Protection Act, with provisions on the regulation of over-the-counter derivatives
Implementation of H.R. 3590, the Patient Protection and Affordable Care Act, to provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes. Implementation of H.R. 4872, the Health Care and Reconciliation Act of 2010, a bill that makes a number of health-related financing and revenue changes to the Patient Protection and Affordable Care Act, specifically regarding the medical device tax. S.540, Medical Device Safety Act, a bill that would remove federal preemption protection for certain medical devices H.R.1346, Medical Device Safety Act, a bill that would remove federal preemption protection for certain medical devices Reform of the 510 (k) regulatory pathway H.R. 759, Food and Drug Administration Globalization Act, a bill to improve the safety of food, drugs, devices, and cosmetics S. 882, the Drug and Device Accountability Act, a bill to ensure the safety and quality of medical products and enhance the authorities of the FDA H.R. 2502, Comparative Effectiveness Research Act of 2009, a bill to provide for the conduct of comparative effectiveness research for drugs, devices, and other therapies and create a Comparative Effectiveness Research Trust Fund S.1213, Patient-Centered Outcomes Research Act of 2009, a bill to provide for the conduct of comparative effectiveness research for drugs, devices, and other therapies and to establish a Patient-Centered Outcomes Research Trust Fund H.R. 2824, Doctor-Patient Relationship and Research Protection Act, a bill to support federally funded comparative effectiveness research for drugs, devices, and other therapies S.1142, Informed Health Care Decision Making Act, a bill with respect to the inclusion of effectiveness information in drug and device labeling and advertising H.R. 3090, Health Equity & Accountability Act of 2009, provides for the elimination of racial and ethnic health disparities S.660, National Pain Care Policy Act, a bill to promote greater access to chronic pain therapies H.R. 756, National Pain Care Policy Act, a bill to promote greater access to chronic pain therapies H.R. 4700, the Transparency in All Health Care Pricing Act of 2010, to provide for transparency in health care pricing H.R. 2249, the Health Care Price Transparency Promotion Act of 2009, to provide for increased price transparency of hospital information and to provide for additional research on consumer information on charges and out-of-pocket costs. H.R. 4803, the Patients Right to Know Act, to ensure health care consumer and provider access to certain health benefits plan information and to amend title XIX of the Social Security Act to provide transparency in hospital price and quality information. H.R.1032, Heart Disease Education, Analysis Research, and Treatment for Women Act to amend the Public Health Service Act to improve the prevention, diagnosis, and treatment of heart disease, stroke, and other cardiovascular diseases in women. S.422, Heart Disease Education, Analysis Research, and Treatment for Women Act to amend the Public Health Service Act to improve the prevention, diagnosis, and treatment of heart disease, stroke, and other cardiovascular diseases in women.
S.660, National Pain Care Policy Act, a bill to promote greater access to chronic pain therapies H.R. 756, National Pain Care Policy Act, a bill to promote greater access to chronic pain therapies S.1380, Medicare Payment Advisory Commission (MedPAC) Reform Act, a bill to make the commission an executive branch agency, and provide the Commission new resources and authority to implement Medicare payment policy S.301, Physician Payments Sunshine Act, a bill that would require disclosure of the relationships between physicians and the manufacturers of drugs and devices H.R. 3138, Physician Payments Sunshine Act, a bill that would require disclosure of the relationships between physicians and the manufacturers of drugs and devices H.R. 2502, Comparative Effectiveness Research Act of 2009, a bill to provide for the conduct of comparative effectiveness research for drugs, devices, and other therapies and create a Comparative Effectiveness Research Trust Fund S.1213, Patient-Centered Outcomes Research Act of 2009, a bill to provide for the conduct of comparative effectiveness research for drugs, devices, and other therapies and to establish a Patient-Centered Outcomes Research Trust Fund H.R. 2824, Doctor-Patient Relationship and Research Protection Act, a bill to support federally funded comparative effectiveness research for drugs, devices, and other therapies S.1142, Informed Health Care Decision Making Act, a bill with respect to the inclusion of effectiveness information in drug and device labeling and advertising H.R. 4700, the Transparency in All Health Care Pricing Act of 2010, to provide for transparency in health care pricing H.R. 2249, the Health Care Price Transparency Promotion Act of 2009, to provide for increased price transparency of hospital information and to provide for additional research on consumer information on charges and out-of-pocket costs. H.R. 4803, the Patients Right to Know Act, to ensure health care consumer and provider access to certain health benefits plan information and to amend title XIX of the Social Security Act to provide transparency in hospital price and quality information
S.515. Patent Reform Act of 2009, provisions related specifically to innovative technologies H.R. 1260, Patent Reform Act of 2009, provisions related specifically to innovative technologies H.R.5322, Patent and Trademark Office Funding Stabilization Act of 2010, provisions related specifically to innovative technologies H.R. 4954, to provide recourse under the patent law for persons who suffer competitive injury as a result of false markings
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE, Transportation, Dept of (DOT)
HR 2749, Food Safety Enhancement Act of 2009, grants FDA the authority and resources to oversee the safety of the nation's food supply. Includes provisions related to registration fees, device import safety fees, and unique identifier provisions.
Implementation of H.R. 3590, the Patient Protection and Affordable Care Act, to provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes. Implementation of H.R. 4872, the Health Care and Reconciliation Act of 2010, a bill that makes a number of health-related financing and revenue changes to the Patient Protection and Affordable Care Act, specifically regarding the medical device tax. S.540, Medical Device Safety Act, a bill that would remove federal preemption protection for certain medical devices H.R.1346, Medical Device Safety Act, a bill that would remove federal preemption protection for certain medical devices Reform of the 510 (k) regulatory pathway H.R. 759, Food and Drug Administration Globalization Act, a bill to improve the safety of food, drugs, devices, and cosmetics S. 882, the Drug and Device Accountability Act, a bill to ensure the safety and quality of medical products and enhance the authorities of the FDA H.R. 2502, Comparative Effectiveness Research Act of 2009, a bill to provide for the conduct of comparative effectiveness research for drugs, devices, and other therapies and create a Comparative Effectiveness Research Trust Fund S.1213, Patient-Centered Outcomes Research Act of 2009, a bill to provide for the conduct of comparative effectiveness research for drugs, devices, and other therapies and to establish a Patient-Centered Outcomes Research Trust Fund H.R. 2824, Doctor-Patient Relationship and Research Protection Act, a bill to support federally funded comparative effectiveness research for drugs, devices, and other therapies S.1142, Informed Health Care Decision Making Act, a bill with respect to the inclusion of effectiveness information in drug and device labeling and advertising H.R. 3090, Health Equity & Accountability Act of 2009, provides for the elimination of racial and ethnic health disparities S.660, National Pain Care Policy Act, a bill to promote greater access to chronic pain therapies H.R. 756, National Pain Care Policy Act, a bill to promote greater access to chronic pain therapies H.R. 4700, the Transparency in All Health Care Pricing Act of 2010, to provide for transparency in health care pricing H.R. 2249, the Health Care Price Transparency Promotion Act of 2009, to provide for increased price transparency of hospital information and to provide for additional research on consumer information on charges and out-of-pocket costs. H.R. 4803, the Patients Right to Know Act, to ensure health care consumer and provider access to certain health benefits plan information and to amend title XIX of the Social Security Act to provide transparency in hospital price and quality information
The FY2011 budget proposal and provisions related to the taxation of foreign earnings of U.S. multinational corporations S.1203, the GROWTH Act, a bill to extend the research credit through 2010 and to increase and make permanent the alternative simplified research credit HR 4213, American Jobs and Closing Tax Loopholes Act, a bill that includes extension of the R&D tax credit
H.R. 4016, the Hazardous Materials Transportation Safety Act of 2009, specifically regarding the transportation of lithium batteries
S.515. Patent Reform Act of 2009, provisions related specifically to innovative technologies H.R. 1260, Patent Reform Act of 2009, provisions related specifically to innovative technologies H.R.5322, Patent and Trademark Office Funding Stabilization Act of 2010, provisions related specifically to innovative technologies
H.R. 3795, to enact the Over-the-Counter Derivatives Markets Act of 2009, provisions related to changing the regulation on over-the-counter derivatives and how they are used by corporations H.R.4173, to provide for financial regulatory reform, to protect consumers and investors, to enhance Federal understanding of insurance issues, to regulate over-the-counter derivatives markets, and for other purposes with provisions specifically changing the regulation on over-the-counter derivatives and how they are used by corporations. S.3217, The Restoring American Financial Stability Act, on financial reform with provisions on the regulation of over-the-counter derivatives Conference Report H. Rept 111-517,Wall Street Reform and Consumer Protection Act, with provisions on the regulation of over-the-counter derivatives
Filing targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE, Transportation, Dept of (DOT)
S.660, National Pain Care Policy Act, a bill to promote greater access to chronic pain therapies H.R. 756, National Pain Care Policy Act, a bill to promote greater access to chronic pain therapies S.1380, Medicare Payment Advisory Commission (MedPAC) Reform Act, a bill to make the commission an executive branch agency, and provide the Commission new resources and authority to implement Medicare payment policy S.301, Physician Payments Sunshine Act, a bill that would require disclosure of the relationships between physicians and the manufacturers of drugs and devices H.R. 3138, Physician Payments Sunshine Act, a bill that would require disclosure of the relationships between physicians and the manufacturers of drugs and devices H.R. 2502, Comparative Effectiveness Research Act of 2009, a bill to provide for the conduct of comparative effectiveness research for drugs, devices, and other therapies and create a Comparative Effectiveness Research Trust Fund S.1213, Patient-Centered Outcomes Research Act of 2009, a bill to provide for the conduct of comparative effectiveness research for drugs, devices, and other therapies and to establish a Patient-Centered Outcomes Research Trust Fund H.R. 2824, Doctor-Patient Relationship and Research Protection Act, a bill to support federally funded comparative effectiveness research for drugs, devices, and other therapies S.1142, Informed Health Care Decision Making Act, a bill with respect to the inclusion of effectiveness information in drug and device labeling and advertising
H.R. 4016, the Hazardous Materials Transportation Safety Act of 2009, specifically regarding the transportation of lithium batteries
H.R. 3795, to enact the Over-the-Counter Derivatives Markets Act of 2009, provisions related to changing the regulation on over-the-counter derivatives and how they are used by corporations H.R.4173, to provide for financial regulatory reform, to protect consumers and investors, to enhance Federal understanding of insurance issues, to regulate over-the-counter derivatives markets, and for other purposes with provisions specifically changing the regulation on over-the-counter derivatives and how they are used by corporations. S.3217, The Restoring American Financial Stability Act, on financial reform with provisions on the regulation of over-the-counter derivatives
HR 2749, Food Safety Enhancement Act of 2009, grants FDA the authority and resources to oversee the safety of the nation's food supply. Includes provisions related to registration fees, device import safety fees, and unique identifier provisions.
S.515. Patent Reform Act of 2009, provisions related specifically to innovative technologies H.R. 1260, Patent Reform Act of 2009, provisions related specifically to innovative technologies
Filing targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT)
H.R. 3590, the Patient Protection and Affordable Care Act, the legislative vehicle used to pass Leader Reid's manager's amendment regarding health care reform on the Senate floor H.R. 3962, Affordable Health Care for America Act,to provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes Other Senate and House Committee Health Reform bills with an emphasis on physician disclosure, comparative effectiveness research, pain research, Medicare secondary payer, bundling, gainsharing, medical device registry, and medical device tax. Medicare Secondary Payer provision, which was included in Ways and Means Chairman's Mark for HR 3200, the America's Affordable Health Choices Act, that would have increased exposure to liability for suppliers S.540, Medical Device Safety Act, a bill that would remove federal preemption protection for certain medical devices H.R.1346, Medical Device Safety Act, a bill that would remove federal preemption protection for certain medical devices Reform of the 510 (k) regulatory pathway H.R. 759, Food and Drug Administration Globalization Act, a bill to improve the safety of food, drugs, devices, and cosmetics S. 882, the Drug and Device Accountability Act, a bill to ensure the safety and quality of medical products and enhance the authorities of the FDA H.R. 2502, Comparative Effectiveness Research Act of 2009, a bill to provide for the conduct of comparative effectiveness research for drugs, devices, and other therapies and create a Comparative Effectiveness Research Trust Fund S.1213, Patient-Centered Outcomes Research Act of 2009, a bill to provide for the conduct of comparative effectiveness research for drugs, devices, and other therapies and to establish a Patient-Centered Outcomes Research Trust Fund H.R. 2824, Doctor-Patient Relationship and Research Protection Act, a bill to support federally funded comparative effectiveness research for drugs, devices, and other therapies S.1142, Informed Health Care Decision Making Act, a bill with respect to the inclusion of effectiveness information in drug and device labeling and advertising H.R. 3090, Health Equity &Accountability Act of 2009, provides for the elimination of racial and ethnic health disparities S.660, National Pain Care Policy Act, a bill to promote greater access to chronic pain therapies H.R. 756, National Pain Care Policy Act, a bill to promote greater access to chronic pain therapies S.1390, the Defense Authorization Bill, provisions related to pain management which would require a comprehensive pain care policy on pain management by the military health care system
H.R. 3795, to enact the Over-the-Counter Derivatives Markets Act of 2009, provisions related to changing the regulation on over-the-counter derivatives and how they are used by corporations H.R.4173, to provide for financial regulatory reform, to protect consumers and investors, to enhance Federal understanding of insurance issues, to regulate over-the-counter derivatives markets, and for other purposes with provisions specifically changing the regulation on over-the-counter derivatives and how they are used by corporations Senate draft legislation by Senator Dodd on financial reform with provisions on the regulation of over-the-counter derivatives
Medical device tax as included as a means to pay for health care reform in H.R. 3962, the Affordable Health Care for America Act and the Senate Manager's Amendment (SA3298) on health care reform H.Con Res 85 and S.Con Res 13, the FY2010 budget resolution and provisions related to the taxation of foreign earnings of U.S. multinational corporations H.R. 4213, the Tax Extenders Act of 2009, specifically including a provision to extend the research and development tax credit S.1203, the GROWTH Act, a bill to extend the research credit through 2010 and to increase and make permanent the alternative simplified research credit
HR 2749, Food Safety Enhancement Act of 2009, grants FDA the authority and resources to oversee the safety of the nation's food supply. Includes provisions related to registration fees, device import safety fees, and unique identifier provisions.
S.515. Patent Reform Act of 2009, provisions related specifically to innovative technologies H.R. 1260, Patent Reform Act of 2009, provisions related specifically to innovative technologies
H.R. 4016, the Hazardous Materials Transportation Safety Act of 2009, specifically regarding the transportation of lithium batteries
Filing targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE
Medical Device tax as mentioned as a proposal to pay for health reform H.Con Res 85 and S.Con Res 13, the FY2010 budget resolution, and provisions related to the taxation of foreign earnings of U.S. multinational corporations H.R. 422, a bill to permanently extend and strengthen the federal R & D tax credit S.1203, the GROWTH Act, a bill to extend the research credit through 2010 and to increase and make permanent the alternative simplified research credit
S.1679, the Affordable Health Choices Act, to provide affordable, quality health care for all Americans H.R. 3200, America's Affordable Health Choices Act of 2009, to provide affordable, quality health care for all Americans Other Senate and House Committee Health Reform bills with an emphasis on physician disclosure, comparative effectiveness research, pain research, medicare secondary payer, bundling, gainsharing, medical device registry, and medical device tax. Medicare Secondary Payer provision, which was included in Ways and Means Chairman's Mark for HR 3200, the America's Affordable Health Choices Act, that would have increased exposure to liability for suppliers S.540, Medical Device Safety Act, a bill that would remove federal preemption protection for certain medical devices H.R.1346, Medical Device Safety Act, a bill that would remove federal preemption protection for certain medical devices Reform of the 510 (k) regulatory pathway H.R. 759, Food and Drug Administration Globalization Act, a bill to improve the safety of food, drugs, devices, and cosmetics S. 882, the Drug and Device Accountability Act, a bill to ensure the safety and quality of medical products and enhance the authorities of the FDA H.R. 2502, Comparative Effectiveness Research Act of 2009, a bill to provide for the conduct of comparative effectiveness research for drugs, devices, and other therapies and create a Comparative Effectiveness Research Trust Fund S.1213, Patient-Centered Outcomes Research Act of 2009, a bill to provide for the conduct of comparative effectiveness research for drugs, devices, and other therapies and to establish a Patient-Centered Outcomes Research Trust Fund H.R. 2824, Doctor-Patient Relationship and Research Protection Act, a bill to support federally funded comparative effectiveness research for drugs, devices, and other therapies S.1142, Informed Health Care Decision Making Act, a bill with respect to the inclusion of effectiveness information in drug and device labeling and advertising H.R. 3090, Health Equity &Accountability Act of 2009, provides for the elimination of racial and ethnic health disparities S.660, National Pain Care Policy Act, a bill to promote greater access to chronic pain therapies H.R. 756, National Pain Care Policy Act, a bill to promote greater access to chronic pain therapies S.1390, the Defense Authorization Bill, provisions related to pain management which would require a comprehensive pain care policy on pain management by the military health care system
S.560, the Employee Free Choice Act, a bill to establish an efficient system to enable employees to form, join, or assist labor organizations and to provide for mandatory injunctions for unfair labor practices during the organizing efforts H.R. 1409, the Employee Free Choice Act, a bill to establish an efficient system to enable employees to form, join, assist labor organizations, and to provide for mandatory injunctions for unfair labor practices during the organizing efforts
HR 2749, Food Safety Enhancement Act of 2009, grants FDA the authority and resources to oversee the safety of the nation's food supply. Includes provisions related to registration fees, device import safety fees, and unique identifier provisions.
S.515. Patent Reform Act of 2009, provisions related specifically to innovative technologies H.R. 1260, Patent Reform Act of 2009, provisions related specifically to innovative technologies
H.R. 3795, to enact the Over-the-Counter Derivatives Markets Act of 2009, provisions related to changing the regulation on over-the-counter derivatives and how they are used by corporations
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
Over the Counter Derivatives, provisions related to changing the regulation
S.560, the Employee Free Choice Act, a bill to establish an efficient system to enable employees to form, join, or assist labor organizations and to provide for mandatory injunctions for unfair labor practices during the organizing efforts H.R. 1409, the Employee Free Choice Act, a bill to establish an efficient system to enable employees to form, join, assist labor organizations, and to provide for mandatory injunctions for unfair labor practices during the organizing efforts
S.660, National Pain Care Policy Act, a bill to promote greater access to chronic pain therapies H.R. 756, National Pain Care Policy Act, a bill to promote greater access to chronic pain therapies S.1380, Medicare Payment Advisory Commission (MedPAC) Reform Act , a bill to make the commission an executive branch agency, and provide the Commission new resources and authority to implement Medicare payment policy S.301, Physician Payments Sunshine Act, a bill that would require disclosure of the relationships between physicians and the manufacturers of drugs and devices H.R. 3138, Physician Payments Sunshine Act, a bill that would require disclosure of the relationships between physicians and the manufacturers of drugs and devices H.R. 2502, Comparative Effectiveness Research Act of 2009, a bill to provide for the conduct of comparative effectiveness research and create a Comparative Effectiveness Research Trust Fund S.1213, Patient-Centered Outcomes Research Act of 2009, a bill to provide for the conduct of comparative effectiveness research and to establish a Patient-Centered Outcomes Research Trust Fund H.R. 2824, Doctor-Patient Relationship and Research Protection Act, a bill to support federally funded comparative effectiveness research relating to health care S.1142, Informed Health Care Decision Making Act, a bill with respect to the inclusion of effectiveness information in drug and device labeling and advertising Medicare coverage of PLATINUM clinical trial
HR. 2454, American Clean Energy and Security Act, a bill to create clean energy jobs, achieve energy independence, reduce global warming pollution and transition to a clean energy economy S.5 a bill to reduce the dependence on foreign and unsustainable energy sources and risks of global warming
Senate and House Committee Health Reform bills with an emphasis on physician disclosure, comparative effectiveness research, pain research, bundling and gainsharing S.540, Medical Device Safety Act, a bill that would remove federal preemption protection for certain medical devices H.R.1346, Medical Device Safety Act, a bill that would remove federal preemption protection for certain medical devices Reform of the 510 (k) regulatory pathway H.R. 759, Food and Drug Administration Globalization Act, a bill to improve the safety of food, drugs, devices, and cosmetics S. 882, the Drug and Device Accountability Act, a bill to ensure the safety and quality of medical products and enhance the authorities of the FDA H.R. 2502, Comparative Effectiveness Research Act of 2009, a bill to provide for the conduct of comparative effectiveness research and create a Comparative Effectiveness Research Trust Fund S.1213, Patient-Centered Outcomes Research Act of 2009, a bill to provide for the conduct of comparative effectiveness research and to establish a Patient-Centered Outcomes Research Trust Fund H.R. 2824, Doctor-Patient Relationship and Research Protection Act, a bill to support federally funded comparative effectiveness research relating to health care S.1142, Informed Health Care Decision Making Act, a bill with respect to the inclusion of effectiveness information in drug and device labeling and advertising
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
HR 422, a bill to permanently extend and strengthen the federal R&D tax credit Deferral tax as mentioned in the President's proposed budget for 2010
HR 1346 Medical Device Safety Act of 2009, a bill that would remove federal preemption protection for certain medical devices S 540 Medical Device Safety Act of 2009, a bill that would remove federal preemption protection for certain medical devices Reform of the 510(k) regulatory pathway Healthcare Reform
HR1- American Recovery and Reinvestment Act of 2009, buy america provision
Market Access, regulatory approvals and reimbursement for medical devices in Japan, EU, Korea, China, Brazil Trade agreements with Columbia and South Korea
S 515 Patent Reform Act of 2009, provisions related specifically to innovative technologies HR 1260 Patent Reform Act of 2009, provisions related specifically to innovative technologies
S.5 a bill to reduce the dependence on foreign and unsustainable energy sources and risks of global warming Johanns Amendment 735 to the Senate Budget Resolution regarding the capp and trade system
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
- S. 2160 Veterans Pain Care Act, a bill to promote greater access to chronic pain therapies in the VA medical system. - HR 6122 Veterans Pain Care Act, a bill to promote greater access to chronic pain therapies in the VA medical system. - S. 2162 Veterans Mental Health and Other Care Improvements Act, a bill to promote greater access to chronic pain therapies in the VA medical system.
- HR 6331 Medicare Improvements for Patients and Providers Act of 2008, possible inclusion of remote monitoring provisions. - HR 5765 Medicare Remote Monitoring Access Act, a bill to provide Medicare reimbursement for doctors who remotely monitor chronically ill patients. - HR 2994 National Pain Care Policy Act, a bill to promote greater access to chronic pain therapies. - S. 3387 National Pain Care Policy Act, a bill to promote greater access to chronic pain therapies. - S. 631 Remote Monitoring Access Act of 2007a bill to provide Medicare reimbursement for doctors who remotely monitor chronically ill patients. - S. 2029 Physican Payments Sunshine Act, a bill that would require disclosure of the relationships between physicians and the manufacturers of drugs and devices. - HR 5605 Physican Payments Sunshine Act, a bill that would require disclosure of the relationships between physicians and the manufacturers of drugs and devices. - Medicare Coverage of Intracranial Angioplasty and Stenting. - Medicare Payment of Inpatient Hospital Services. - Medicare Coverage of Renal Stenting. - Medicare Coverage of Carotid Stenting. - Regulatory and Reimbursement Issues for Medical Devices in Medicare. - S. 3408 Comparative Effectiveness Research Act to compare cinical effectiveness of medical treatments, services and items.
- HR 5465 Military Pain Care Act, a bill to promote greater access to chronic pain therapies in the DoD healthcare system. - HR 5658 Duncan Hunter National Defense Authorization Act for Fiscal Year 2009, provisions to promote greater access to chronic pain therapies in the DoD healthcare system. - S. 3002 Department of Defense Authorization Act, provisions to promote greater access to chronic pain therapies in the DoD healthcare system.
- Food and Drug Administration Globalization Act of 2008, a bill to increase FDA inspection of manufacturers in the US and abroad. - HR 6381Medical Device Safety Act of 2008, a bill that would remove federal preemption protection for certain medical devices. - HR 2900 Implementation of Food and Drug Administration Amendments Act of 2007, a bill to revise and extend the user-fee programs for prescription drugs and for medical devices. - HR 3014 Health Disparities, a bill to address disparities in the delivery of health care, specifically as it relates to cardiovascular care. - S. 3398 Medical Device Safety Act of 2008, a bill that would remove federal preemption protection for certain medical devices. - HR 6432 Animal Drug User Fee Act, a provision to make technical corrections to device user fee program.
- S.1145 Patent Reform Act of 2007, provisions related specifically to innovative technologies. - HR 1908 Patent Reform Act of 2007, provisions related specifically to innovative technologies.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Intl Trade Administration (ITA), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
- S.1145 Patent Reform Act of 2007, provisions related specifically to innovative technologies. - HR 1908 Patent Reform Act of 2007, provisions related specifically to innovative technologies.
- Market Access, regulatory approvals and reimbursement for medical devices in Japan, EU, Korea, China, Brazil. - Trade Agreements with Columbia, South Korea.
- HR 5465 Military Pain Care Act, a bill to promote greater access to chronic pain therapies in the DoD healthcare system. - HR 5658 Duncan Hunter National Defense Authorization Act for Fiscal Year 2009, provisions to promote greater access to chronic pain therapies in the DoD healthcare system. - S. 3002 Department of Defense Authorization Act, provisions to promote greater access to chronic pain therapies in the DoD healthcare system.
- HR 6331 Medicare Improvements for Patients and Providers Act of 2008, possible inclusion of remote monitoring provisions. - HR 5765 Medicare Remote Monitoring Access Act, a bill to provide Medicare reimbursement for doctors who remotely monitor chronically ill patients. - HR 2994 National Pain Care Policy Act, a bill to promote greater access to chronic pain therapies. - S. 3387 National Pain Care Policy Act, a bill to promote greater access to chronic pain therapies. - S. 631 Remote Monitoring Access Act of 2007a bill to provide Medicare reimbursement for doctors who remotely monitor chronically ill patients. - S. 2029 Physican Payments Sunshine Act, a bill that would require disclosure of the relationships between physicians and the manufacturers of drugs and devices. - HR 5605 Physican Payments Sunshine Act, a bill that would require disclosure of the relationships between physicians and the manufacturers of drugs and devices. - Medicare Coverage of Intracranial Angioplasty and Stenting. - Medicare Payment of Inpatient Hospital Services. - Medicare Coverage of Renal Stenting. - Medicare Coverage of Carotid Stenting. - Regulatory and Reimbursement Issues for Medical Devices in Medicare. - S. 3408 Comparative Effectiveness Research Act to compare cinical effectiveness of medical treatments, services and items.
- S. 2160 Veterans Pain Care Act, a bill to promote greater access to chronic pain therapies in the VA medical system. - HR 6122 Veterans Pain Care Act, a bill to promote greater access to chronic pain therapies in the VA medical system. - S. 2162 Veterans Mental Health and Other Care Improvements Act, a bill to promote greater access to chronic pain therapies in the VA medical system.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Intl Trade Administration (ITA), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
- S.1145 Patent Reform Act of 2007 - HR 1908 Patent Reform Act of 2007
- HR 5465 Military Pain Care Act
- Medical device supplier contract with Veterans Administration - S. 2160 Veterans Pain Care Act
- Regulatory and Reimbursement Issues for Medical Devices in Medicare. - Implementation of Coverage, Coding and Reimbursement under 2003 Medicare Prescription Drug Improvement and Modernization Act. - HR 3162 Children's Health and Medicare Protection Act of 2007 - HR 976, Small Business Tax Relief Act of 2007 - Medicare Coverage of Intracranial Angioplasty and Stenting - Medicare Payment of Inpatient Hospital Services - S. 631 Remote Monitoring Access Act of 2007 - HR 5765 Medicare Remote Monitoring Access Act - Medicare Clinical Research Policy - S. 2029 Physican Payments Sunshine Act -HR 5605 Physican Payments Sunshine Act - S. 2221 Transparency Medical Device Pricing Act - HR 2994 National Pain Care Policy Act - Medicare Coverage of Renal Stenting - Comparative Effectiveness research - S. 999 Stop Stroke - HR 477 Stroke Treatment & Prevention Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Intl Trade Administration (ITA), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
- Food and Drug Administration Globalization Act of 2008, a bill to increase FDA inspection of manufacturers in the US and abroad. - HR 6381Medical Device Safety Act of 2008. a bill that would remove federal preemption protection for certain medical devices. - HR 2900 Implementation of Food and Drug Administration Amendments Act of 2007, a bill to revise and extend the user-fee programs for prescription drugs and for medical devices. - HR 3014 Health Disparities, a bill to address disparities in the delivery of health care, specifically as it relates to cardiovascular care.
- HR 2419 Farm Bill, provisions relating to training physicians using live animals. - S 2302 Farm Bill, provisions relating to training physicians using live animals.
- HR 6331 Medicare Improvements for Patients and Providers Act of 2008, possible inclusion of remote monitoring provisions - HR 5765 Medicare Remote Monitoring Access Act, a bill to provide Medicare reimbursement for doctors who remotely monitor chronically ill patients. - HR 2994 National Pain Care Policy Act, a bill to promote greater access to chronic pain therapies. - S. 631 Remote Monitoring Access Act of 2007a bill to provide Medicare reimbursement for doctors who remotely monitor chronically ill patients. - S. 2029 Physican Payments Sunshine Act, a bill that would require disclosure of the relationships between physicians and the manufacturers of drugs and devices - HR 5605 Physican Payments Sunshine Act, a bill that would require disclosure of the relationships between physicians and the manufacturers of drugs and devices - S. 2221 Transparency Medical Device Pricing Act, a bill that would require thedislosure of pricing for medical devices. - S. 999 Stop Stroke, a bill to improve stroke prevention, diagnosis, treatment, and rehabilitation. - HR 477 Stroke Treatment & Prevention Act, a bill to improve stroke prevention, diagnosis, treatment, and rehabilitation - HR 3162 Children's Health and Medicare Protection Act of 2007, a bill to extend and improve the children's health insurance program. - HR 976, Small Business Tax Relief Act of 2007, a bill to extend and improve the Children's Health Insurance Program. - Medicare Coverage of Intracranial Angioplasty and Stenting - Medicare Payment of Inpatient Hospital Services - Medicare Coverage of Renal Stenting - Comparative Effectiveness research - Medicare Coverage of Carotid Stenting - Regulatory and Reimbursement Issues for Medical Devices in Medicare
- S.1145 Patent Reform Act of 2007, provisions related specifically to innovative technologies. - HR 1908 Patent Reform Act of 2007, provisions related specifically to innovative technologies.
- HR 5465 Military Pain Care Act, a bill to promote greater access to chronic pain therapies in the DoD healthcare system. - HR 5658 Duncan Hunter National Defense Authorization Act for Fiscal Year 2009, provisions to promote greater access to chronic pain therapies in the DoD healthcare system.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Intl Trade Administration (ITA), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
- Medical device supplier contract with Veterans Administration - S. 2160 Veterans Pain Care Act
- S.1145 Patent Reform Act of 2007 - HR 1908 Patent Reform Act of 2007
- HR 2900 Implementation of Food and Drug Administration Amendments Act of 2007 - Medical Device Safety Act 2008 - HR 2419 Farm Bill
- Regulatory and Reimbursement Issues for Medical Devices in Medicare. - Implementation of Coverage, Coding and Reimbursement under 2003 Medicare Prescription Drug Improvement and Modernization Act. - HR 3162 Children's Health and Medicare Protection Act of 2007 - HR 976, Small Business Tax Relief Act of 2007 - Medicare Coverage of Intracranial Angioplasty and Stenting - Medicare Payment of Inpatient Hospital Services - S. 631 Remote Monitoring Access Act of 2007 - HR 5765 Medicare Remote Monitoring Access Act - Medicare Clinical Research Policy - S. 2029 Physican Payments Sunshine Act -HR 5605 Physican Payments Sunshine Act - S. 2221 Transparency Medical Device Pricing Act - HR 2994 National Pain Care Policy Act - Medicare Coverage of Renal Stenting - Comparative Effectiveness research - S. 999 Stop Stroke - HR 477 Stroke Treatment & Prevention Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Intl Trade Administration (ITA), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
- Market Access, regulatory approvals and reimbursement for medical devices in Japan, EU, Korea, China, Brazil - Trade Agreements with Peru, Panama, Colombia, South Korea - HR 3668 United States-Peru Trade Promotion Agreement Implementation Act
- Medical device supplier contract with Veterans Administration
- HR 2138 Investment in America Act of 2007 - S. 2209 Investment in America Act of 2007
- HR 2900 Food and Drug Administration Amendments Act of 2007 - S. 1082 Food and Drug Administration Revitalization Act - HR 1494 Pediatric Medical Device Safety and Improvement Act of 2007 - Update to International Classification of Diseases coding to 10th revision (ICD-10) - HR 2419 Farm Bill
- Regulatory and Reimbursement Issues for Medical Devices in Medicare. - Implementation of Coverage, Coding and Reimbursement under the 2003 Medicare Prescription Drug Improvement and Modernization Act. - HR 3162 Children's Health and Medicare Protection Act of 2007. - HR 976, Small Business Tax Relief Act of 2007 - Medicare Coverage of Intracranial Angioplasty and Stenting - Medicare Payment of Inpatient Hospital Services - S. 631 Remote Monitoring Access Act of 2007 - Medicare Clinical Research Policy - S. 2029 Physician Payments Sunshine Act - S. 2221 Transparency Medical Device Pricing Act - HR 2994 National Paincare Policy Act - Medicare Coverage of Renal Stenting - Comparative Effectiveness research
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Federal Communications Commission (FCC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR), UNDETERMINED, Veterans Affairs, Dept of (VA)
- S. 1145 Patent Reform Act of 2007 - HR 1908 Patent Reform Act of 2007
- HR 2900 Food and Drug Administration Amendments Act of 2007 - S. 1082 Food and Drug Administration Revitalization Act - HR 1494 Pediatric Medical Device Safety and Improvement Act of 2007 - Update to International Classification of Diseases coding to 10th revision (ICD-10)
- Regulatory and Reimbursement Issues for Medical Devices in Medicare. - Implementation of Coverage, Coding and Reimbursement under the 2003 Medicare Prescription Drug Improvement and Modernization Act. - HR 3162 Children's Health and Medicare Protection Act of 2007.
- Use of dedicated spectrum for medical devices
- Medical device supplier contract with Veterans Administration
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Federal Communications Commission (FCC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)